Impact of Medicare and Medicaid Beneficiaries with Selected Conditions on Emergency Department Utilization by Amoh, John K.
Walden University
ScholarWorks
Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral StudiesCollection
2016
Impact of Medicare and Medicaid Beneficiaries




Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Epidemiology Commons, and the Public Health Education and Promotion Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been




















has been found to be complete and satisfactory in all respects,  
and that any and all revisions required by  




Dr. James Rohrer, Committee Chairperson, Public Health Faculty 
Dr. Lawrence Fulton, Committee Member, Public Health Faculty 






Chief Academic Officer 













Impact of Medicare and Medicaid Beneficiaries with Selected Conditions  
on Emergency Department Utilization   
by 
John K. Amoh 
 
MBA, The George Washington University, 1998 
BS, Albright College, 1994 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 
Doctor of Philosophy 







 The contents of this publication are solely the responsibility of the authors and do not necessarily represent 




Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF) are 
conditions that represent significant and ongoing medical costs, including frequent 
emergency department (ED) visits, hospitalizations, work absences, and disability. This 
retrospective cross-sectional study, examined the effects of the frequent ED visits due to 
COPD and CHF on the beneficiaries of Medicare and Medicaid in Maryland. The goal was to 
identify the factors that led these patients to visit the ED, the impact of these visits on 
Medicare utilization and costs across Maryland, and preventative intervention strategies to 
control this population’s costs of care. Secondary data were analyzed from 2010-2012 using 
the Administrative Claims Data in Chronic Condition Warehouse (CCW). The results for the 
first research question revealed that an increase in the number of primary care physicians was 
correlated with a decrease in ED visits; thus, persons living in areas with higher PCPs also 
had lower ED visits therefore the first null hypothesis was rejected (χ2 = 3.85, p=.05) . The 
results for the second research question revealed that ED visits had no significant relationship 
with death in a given year; thus, patients may be diverted to less expensive care sites to 
minimize cost and ED overcrowding, therefore the second null hypothesis was not rejected 
(χ2 = 0, p=.98). In both cases, the confounding variables of gender, age, and race had 
significant effects upon the relationship. Health Professionals and policy makers may use the 
findings to develop strategies to increase supply of PCPs, adapt patient centered interventions 
and modify existing chronic disease care strategies to minimize or prevent lifestyle and 
environmental factors that affect chronic disease outcomes. Such improvements could 
contribute to positive social change by eliminating or reducing the overcrowding that occurs 
in emergency departments in Maryland and other states.  
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Chapter 1: Introduction to the Study  
Introduction  
Chronic Obstructive Pulmonary Disease (COPD) is associated with a significant 
economic burden including frequent emergency department (ED) visits, hospitalization, 
work absence, and disability (Rabe et al., 2007). COPD affects more than 24 million 
adults in the United States (Gold, Phelps, Jacobson, & Neuman, 2010; Mannino, Homa, 
Akinbami, Ford, & Redd, 2002) surpassing stroke as the third leading cause of death 
(Center for Disease Control [CDC], 2010). COPD also affects 12% of elderly adults and 
disabled Medicare beneficiaries and is frequently associated with comorbid conditions 
and increased disease severity (Dalal, Shah, Lunacsek, & Hanania, 2011). In 2007, the 
costs of COPD exceeded $42 billion, with $29.5 billion attributed to direct health care 
expenditures and $8 billion to mortality (National Institutes of Health [NIH], 2012). One 
may determine the severity of COPD and classify it by utilizing various methods. 
Incidence and prevalence estimates differ greatly, depending on the methods used for 
diagnosis and classification. It remains important to understand the true epidemiology of 
COPD to monitor trends over time and to determine the effectiveness of potential 
treatments or preventive measures (Rycroft, Heyes, Lanza, & Becker, 2012).  
Similarly, Congestive Heart Failure (CHF) also represents the most common 
cause of ED visits and hospitalization in the Medicare program, and led to nearly 1.4 
million hospitalizations and $17 billion in total spending in 2007 alone (Medicare 
Payment Advisory Commission [MPAC], 2009). Despite pharmacologic and technical 
advances in the diagnosis and management of CHF, outcomes remain suboptimal: one in 
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10 patients die in the first 30 days after hospitalization for CHF, and of those who 
survive, one in four is readmitted (Krumholz et al., 2009). The high clinical and financial 
burden of this condition, especially among elderly persons, has led to great interest in 
both improving outcomes and decreasing the cost of care (Krumholz et al., 2009).  
This study examined the association between COPD/CHF and the frequent ED 
visits impact on utilization and costs among Maryland Medicare and Medicaid 
beneficiaries. The research identified the characteristics that drive CHF/COPD patients to 
frequent the ED and how they influence utilization and cost across the various counties in 
Maryland. Intervention strategies were examined to help address preventive measures 
and how to control cost of care for such population. This study also assessed how the 
Medicare and Medicaid beneficiaries’ access their Primary Care Physicians (PCPs) as 
well as the epidemiologic triad model (person, time, and place) of those with CHF/COPD 
among Maryland Medicare and Medicaid beneficiaries.  
This study promoted positive social change by supporting research in CHF and 
COPD to assist healthcare providers in focusing more on preventive measures in reducing 
CHF and COPD. The study examined how insurance coverage, access to care, cost, 
location (counties), and other characteristics are related to significant differences in ED 
use in the state of Maryland Medicare and Medicaid general population. Two specific 
case types, CHF and COPD, were examined for the analysis, as these types were known 
as costly to the medical care system (Knowlton et al., 2013).  
Chapter 1 previewed this research including what the study was about along with 
the related literature summaries. Applicable literature reviews were examined under 
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Chapter 2. The study addressed all the specified criteria per the quantitative checklist 
including research questions and hypotheses. 
Background 
While frequent ED use among Medicare and Medicaid beneficiaries in Maryland 
is not well understood, findings from related research on other populations provide 
insight that may be relevant to the Medicare and Medicaid population. In this section, 
articles of frequent ED use are reviewed and relevant information will be synthesized. 
Ultimately, gaps in the literature on frequent ED use will be discussed, as well as how 
this research analysis will further the understanding of ED use among Medicare and 
Medicaid beneficiaries in the state of Maryland. Pines et al. (2011), in a recent literature 
review and expert consensus, identified several gaps in the public health and medical 
literature on frequent ED use. The major challenge to coherently synthesizing results 
from research conducted to date on frequent ED attendance is the lack of a meaningful 
categorization of frequent users in a given year as well as longitudinally across time 
(Pines et al., 2011). The authors call for a more meaningful taxonomy to describe ED 
utilization based not only on frequency but also patterns such as long-term, shot-term, 
and periodic use, admission to the hospital, number of facilities visited, and stratification 
by specific conditions (Pines et al., 2011).  
Mandelberg, Kuhn, and Kohn (2000) observed that the proportional risk of 
frequent use in the elderly is not well understood, as researchers studying data based on 
observations of single ED and population surveys demonstrated low representations of 
older adults. The authors call for interventions focused on patients with chronic frequent 
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use, as these patients may have substantial needs that are not being met in primary care 
(Mandelberg et al., 2000). Gruneir, Silver, and Rochon (2011) found that lack of studies 
on the effect of proactive health services, such as primary care on reducing ED visits, 
represents the most obvious gap in the research literature. Fuda and Immekus (2006) 
found that, in an analysis of claims from all nonfederal, acute-care hospitals in 
Massachusetts, a bimodal distribution in frequent ED use is defined as five or more visits 
annually with increased prevalence in patients aged 25-44 and older than 65. They 
noticed that regression to the mean in frequent users with most returning in frequent or 
nonuse the subsequent year (Fuda & Immekus, 2006). Cook et al.. (2004) observed 
similar trend in a statewide analysis of ED claims from 1996-1998 in Utah finding that 
only 5% of participants were frequent ED users in all 3 years of study. Hunt, Weber, 
Showstack, Colby, and Callaham (2006) made the case that frequent ED use should be 
defined according to the size and impact of the group of patients. Their rationale was that 
persons accounting for a disproportionate share of ED incidents would be an appropriate 
target for intervention (Hunt et al., 2006). They also emphasized that focusing on a group 
that represents 25% of ED events would likely have a substantive impact on the total 
number of ED visits (Hunt et al., 2006).  
LaCalle and Rabin’s (2010) systematic review concluded that there is no 
generally accepted standard of what constitutes frequent ED use. The identified variable 
definitions ranged from two to 14 visits annually and observed that investigators usually 
weigh the sensitivity of a measure in capturing the population of interest against the 
specificity of defining a group that can be targeted for intervention (LaCalle & Rabin, 
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2010). LaCalle and Rabin (2010) advocated for a cut of four or more visits in a calendar 
year, which is commonly used in most literatures. Locker, Baston, Mason, and Nicholl 
(2007) further supported a threshold of four or more visits to classify frequent ED use. 
They projected a theoretical distribution of ED visits to an ED and minor injury unit in 
England. At four visits, the observed frequency plateaued at around 1000 on a 
logarithmic scale, deviating significantly from the expected distribution, which continued 
to decline (Locker et al., 2007). The authors found that 99.99% of chance attenders would 
be expected to show up in ED less than four times in a calendar year (Locker et al., 
2007). Xu, Nelson, and Burke (2009) found that frequent ED users are heavy users of 
other healthcare services; in addition, they have more outpatient visits and 
hospitalizations compared to infrequent ED users.  
This research contributed to the literature on frequent ED use in the state of 
Maryland by examining the persistent and frequent ED use among Medicare 
beneficiaries. This work identified a population of users that are potentially suited to 
public health intervention. This study addressed an important gap in the current research 
by exploring the importance of primary care at the community and individuals level in 
reducing frequent ED use. The goal of this dissertation was to provide health services 
researchers and policy makers with a better understanding of modifiable factors that 
affect frequent ED use to guide future studies and inform the development of targeted 




The 1986 Emergency Medical Treatment and Active Labor Act (EMTALA), 
requires hospitals to perform examinations and provide stabilization treatment before 
transferring a person to another provider (Byrne et al.., 2003; Centers for Medicare & 
Medicaid Services [CMS], 2012). EMTALA offers hospitals no option other than treating 
anyone who comes through the ED. People using ED services and increasing congestion 
in emergency rooms (ERs) in Maryland hospitals has developed into a significant burden 
and represents a concern to Maryland hospitals and lawmakers (Lucas et al., 2009; 
Maryland Health Care Commission [MHCC], 2002). The joint work group on ED 
Utilization conducted a study of ED issues (Cheung, Wiler, Lowe, & Ginde, 2012; 
MHCC, 2002; Tang et al., 2010) and found that, from 1990 to 2001, ED visits rose from 
1.5 million annually to 1.9 million – an increase of 27% (Garcia, Bernstein, & Bush, 
2010). The group also found that hospitals increasingly use temporary closures of EDs to 
manage overcrowding (Fwu, Eggers, Kimmel, Kusek, & Kerala, 2013). As a result, 
ambulance diversions (as measured by hours that hospitals in the state operate on yellow 
alerts status) have risen fourfold between 1996 and 2001 (Fwu et al., 2013). These 
findings in utilization are consistent with the national trend (Affleck Parks, Drummond, 
Rowe, & Ovens, 2013; Burt & McCaig, 2001; McCaig & Nawar, 2006). 
According to LaCalle and Robin (2010); Ruger, Richter, Spitznagel, and Lewis 
(2004); and Locker et al. (2007), frequent ED users are more likely to arrive by 
ambulance and to be admitted to the hospital. While in the hospital, the frequent users 
stay for longer periods (Locker et al., 2007). Several authors, including LaCalle and 
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Robin (2010), Hunt et al. (2006), and Ruger et al. (2004), in a systemic review found that 
frequent ED users are also a resource-intensive population that relies mainly on services 
such as physician and hospital care.  
Medicare beneficiaries are nearly twice as likely compared to privately insured 
individuals to identify as frequent ED users (Hunt et al., 2006). ED uses are particularly 
unhealthy events for older adults, who represent the majority of the Medicare population, 
as they may start a series of adverse events such as hospitalization, readmission, nursing 
homes bound, and death (Gruneir et al., 2011). Identifying individual and health system 
factors associated with frequent ED users in the Medicare and Medicaid population 
remained policy-relevant and would fill the knowledge gap. It would also inform and 
assist Maryland policy makers in allocating scarce resources to bring about a positive 
social change, such as supporting research in CHF and or COPD to assist healthcare 
providers in focusing more on preventive measures in reducing CHF or COPD.  
This researcher examines how insurance coverage, access to care, cost, location 
(counties) and other characteristics are related to the significant differences in ED use in 
the state of Maryland among the Medicare and Medicaid general population. Two 
specific cases types were chosen to adjust for clinical differences among medical care 
users that might bias findings. COPD and CHF were chosen as the case types for this 




Purpose of the Study 
This quantitative study explored whether ED use by Medicare and Medicaid 
beneficiaries in Maryland with CHF and COPD is associated with utilization and cost. 
Dependent variables include two ambulatory care sensitive condition (ACSC) conditions 
(e.g., CHF and COPD) and patient outcomes. Quantitative statistical analysis were used 
to assess ED utilization and cost for patients with CHF/COPD compared to patients who 
did not access ED during the years under consideration, while controlling for and 
evaluating effects of covariates known to affect ED visits. Results were examined to 
ascertain the economic burden on families, states, and the nation. 
This study was unique in addressing the overcrowding in Maryland ED and the 
ways Medicare and Medicaid beneficiaries with CHF and COPD influence the health 
resource utilization and cost. It focused on patients 65 years and over with CHF/COPD, a 
condition that need attention in the state of Maryland. The retrospective quantitative 
design allowed for evaluation of the impact of ED use on acute care hospitals. The 
epidemiological design study assessed hospitals ED characteristics in the counties in the 
states and time of CHF/COPD condition onset.  
Research Questions and Hypotheses 
The primary research objective included drawing from the administrative claims 
data in chronic condition warehouse (CCW) and Medicaid analytic extract files (MAX), 
the researcher examined the importance of primary care, measured at the community and 
individual level, in regard to episodic (1 year) and persistent (2 consecutive years) 
frequent ED use in the calendar years 2011 and 2012. COPD and CHF were chosen as 
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the case types for this analysis because they are known to be costly to the medical care 
system (Knowlton et al., 2013). 
 RQ1. Is the primary care provider (PCP) supply in the State of Maryland 
associated with frequent ED use among Maryland Medicare and Medicaid beneficiaries 
who have either CHF or COPD? 
H01: Increased ratios of PCP to State of Maryland Medicare and Medicaid 
beneficiaries with either CHF or COPD will have no significant 
relationship with number of ER visits by beneficiaries, while controlling 
for age, gender, and race. 
Ha1: Increased ratios of PCP to State of Maryland Medicare and Medicaid 
beneficiaries with either CHF or COPD will have a significant relationship 
with number of ER visits by beneficiaries, while controlling for age, 
gender, and race. 
RQ2. Is frequent ED use associated with end of life for Maryland Medicare and 
Medicaid beneficiaries with either CHF or COPD who die during the study? 
H02: Increased number of visits to the ER will not have a significant 
relationship with death among Maryland Medicare and Medicaid 
beneficiaries with either CHF or COPD while controlling for age, gender, 
and race.  
Ha2: Increased number of visits to the ER will have a significant 
relationship with death among Maryland Medicare and Medicaid 
10 
 
beneficiaries with either CHF or COPD while controlling for age, gender, 
and race.  
Theoretical Foundation 
According to Andersen’s model of health behavior, utilization of health services 
is determined by chain of predisposing characteristics, enabling resources, and need 
(Andersen, 2008). Need, both perceived and evaluated, represents the proximate 
determinant of health services utilization (Andersen, 2008). However, predisposing 
factors, such as sociodemographic characteristics and health beliefs, place certain 
individuals at greater risk for developing an illness (need), and enabling resources such as 
community resources and access to primary care influence the seeking of medical 
services to address needs (Andersen, 2008). When need is the primary determinant of 
health service utilization, rather than predisposing characteristics or enabling resources, 
access to services is assumed to be equitable (Andersen, 2008). On the contrary, if 
predisposing characteristics and enabling resource explain more variance in health 
service utilization, it suggests inequity in utilization (Andersen, 2008) access and quality.  
Andersen updated this model in 2008 to reflect the importance of contextual 
characteristics as well as individual determinants of health service utilization (Andersen, 
2008). Contextual characteristics can predispose (as in the demographic composition of a 
community), enable (as the supply of medical personnel and facilities), or suggest need 
for health services (as in mortality and morbidity rates; Andersen, 2008). These factors 
interact with individual characteristics, which predispose, enable, or suggest need for 
health services, as discussed in the previous paragraph. The contextual and individual 
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characteristics in turn lead to health behavior such as personal health practices (i.e., 
nutrition and fitness), processes of medical care (i.e., physician-patient communication, 
ordering certain tests or prescriptions), and use of personal health services (e.g., physician 
and ED visits; Andersen, 2008). Ultimately, these factors result in the outcomes of 
perceived health, evaluated health, and consumer satisfaction (Andersen, 2008). 
This study focused on the usage of one type of health services: ED use. The main 
contextual variables of interest will be measures of insurance coverage, at two levels: (a) 
the number of beneficiaries with Medicare coverage who frequent the ED and (b) the 
number of beneficiaries with Medicaid coverage who frequent the ED. Other contextual 
level variables such as case type, cost, sociodemographic composition and health indices 
of the community will be used as controls. Individual level variables relating to 
predisposing characteristics such as race, age, and Medicaid eligibility, and need (e.g., 
chronic disease diagnoses and Health Care Commission [HCC] scores) were also used as 
controls to help isolate the effects of primary care factors.  
The Epidemiological Triad Model is a common model used in public health 
illustrates the relationships among an agent, a host, and the environment (Andersen, 
2008). This, as used in communicable disease, is basic and foundational to all 
epidemiology (Andersen, 2008). However, infectious diseases are no longer the leading 
cause of death in industrialized nations (Andersen, 2008). As a result, a more advanced 
model of the triangle of epidemiology has been developed (Andersen, 2008). The new 
model includes all aspects of the communicable disease model and it is useful with the 
current causes of diseases, conditions, disorders, defects, injury, and death reflecting 
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current causes of illness and conditions (Andersen, 2008). Behavior, lifestyle factors, 
environmental causes, ecological elements, physical factors, and chronic diseases have 
been accounted for (Lilienfeld & Lilienfeld, 1980). 
Figure 1 presents an adapted and advanced model of the triangle of epidemiology, 
better reflecting the behavior, lifestyle, and chronic disease issues found in modern times. 
The advanced model recognizes that disease states and conditions affecting a population 
are complex and that causative factors are many (Lilienfeld & Lilienfeld, 1980). It gives 
recognition to the fact that many factors and elements contribute to disease in 
populations. 
 
Figure 1. Advanced model of the triangle of epidemiology. Adapted from Foundations of 
Epidemiology, 2nd ed. p. 14. 
Nature of the Study 
This study consisted of retrospective analyses of secondary administrative claims 
from the Medicare program for calendar year 2010-2012 and a corresponding 100% 
Medicaid administrative claims data for the same years under consideration. A 20% 
Time 
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sample of the CCW, which includes approximately 10 million Medicare beneficiaries in 
any given recent calendar year, was analyzed for the study with specific emphasis on the 
state of Maryland (Buccaneer, 2011). CMS (2012), in partnership with Buccaneer 
Computing and Software Services, launched the CCW in 2005 as a means of linking 
claims by beneficiary across the continuum of care (Buccaneer, 2011). Using a unique 
beneficiary identification number, information regarding inpatient, outpatient, skilled 
nursing facility, home health, hospice, and Part D prescription drug use may be linked to 
demographic and assessment data for a given beneficiary (Buccaneer, 2011). The CCW 
only administrates claims for beneficiaries enrolled in fee-for-service (FFS) Medicare; 
encounter data for beneficiaries in Medicare Advantage (MA) managed care plans are 
maintained by private health plans (Buccaneer, 2011). The MAX data, on the other hand, 
is a set of person-level data files on Medicaid eligibility, service utilization, and payments 
(Buccaneer, 2011). The MAX data are created to support research and policy analysis 
(Buccaneer, 2011). The MAX data are extracted from the Medicaid Statistical 
Information System (MSIS; Buccaneer, 2011). 
Definitions 
Ambulatory care sensitive condition (ACSC): Chronic diseases for which there is 
wide variation in hospitalization rates and for which had better access to and quality of 
primary care is believed to reduce unnecessary hospitalization (Oster & Bondmen, 2005). 
Continuity of Care (COC): The period that Medicare and Medicaid beneficiaries 
with CHF/COPD visited their primary care physician consistently in managing their 
condition within the study period (Bayliss et al., 2015; Wolinsky et al., 2007).  
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Frequent Emergency Department visit: Four or more ED visits in a calendar year 
(LaCalle & Rabin, 2010).  
Assumptions 
The research depended on the administrative data for Medicare and Medicaid in 
analyzing the impact of utilization and cost on ED visits by beneficiaries with CHF and 
COPD. For the purposes of this study, it is assumed that all the beneficiaries experiencing 
CHF/COPD will access ED, though it is likely that some may access other means of 
heath care, which may or may not be captured in the data used.  
It is assumed that an evidence of COC will help manage beneficiaries’ condition 
thereby minimizing the frequent ED visits associated with CHF/COPD patients. In 
general, beneficiaries who experience chronic illness may be taking prescribed 
medication (Philipson, Snider, Lakdawalla, Stryckman, & Goldman, 2013). However, 
this researcher anticipated that this bias might be minimized by controlling for related 
covariates. 
Scope and Delimitations  
This study examined the Maryland Medicare and Medicaid beneficiaries (age 65 
or over) with CHF and COPD conditions. Beneficiaries with these two chronic conditions 
were selected for this study because they are among the leading causes of death in the 
U.S. and their potential impact on ED utilization and cost are alarming (Aziz et al., 2011). 
The burden of the selected conditions (CHF/COPD) on families, local governments, and 
the nation merit a special attention and understanding of the characteristics that drives ED 
visits and cost. Knowing these will assist health professionals and policy makers in 
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controlling these public health issues through prevention measures. While there is 
previous evidence of CHF and COPD interventions to minimize the impact of these two 
conditions, more needs to be done with respect to prevention. In addition, CHF and 
COPD are among the health conditions flagged by CMS (2012) as high-risk population 
and having high readmission rate (Aziz et al., 2011; Kociol et al., 2013). Therefore, this 
study focused on beneficiaries with these two diagnoses. 
Other studies have focused on adults (18 years and over) because patients at any 
age may experience any of the two conditions, this study included only Medicare and 
Medicaid beneficiaries 65 years and over who reside in the state of Maryland. Only 
beneficiaries exclusively diagnosed with CHF/COPD access the ED were considered. 
While there are other subgroups suffering from the selected conditions in Maryland, it 
was not feasible to include such groups. 
The results of this study could potentially apply to other states within U.S. as well 
as hospitals across the nation that experience overcrowding in their EDs with Medicare 
and Medicaid beneficiaries afflicted with CHF and COPD. While there may be variations 
between hospitals, depending on the extent of patient condition and the frequency with 
which the patients access ED, geographic location of beneficiaries and other relevant 
covariates were included in the study.  
Limitations 
CHF/COPD prevention may be encouraged through exercise, diet, and medication 
or in some cases invasive surgery (Hannan et al., 2008). Nevertheless, a combination of 
different approaches may be employed for a maximum outcome. An attempt was made to 
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control confounding variables; however, not all covariates related to frequent ED visits 
were identified. For instance, the lack of availability of an appropriate rehabilitation 
environment after ED/hospital might have significantly influenced patients’ health 
outcomes. Therefore, literature from previous studies was assessed to determine other 
relevant variables likely to affect COC.  
Design and or Methodological Weaknesses  
This study attempted to produce results that may apply to other states and hospital 
settings and potentially other chronic condition diagnoses (Hannan et al., 2008). Afflicted 
patients with one chronic condition are generally lacking physical activities, eating 
poorly, and or are sicker compared to average patients with one chronic condition 
(Philipson et al., 2013). Any likely weakness were controlled for during the analyses. 
Patients with congestive heart failure may have large amounts of fluid retention; 
therefore, weights might have varied and some weight loss might have associated with 
improvement in condition. 
Biases 
The biggest potential bias might have included selection bias; meaning, patients 
with CHF/COPD, no Medicare, and no Medicaid benefits were not considered for this 
study. CHF/COPD screening of patients in hospitals within 24 hours is a national 
standard of the Joint Commission (TJC; Somanchi, Tao, & Mullin, 2011). I overcame 
this bias by adjusting for CHF/COPD risk, as well as other factors affecting ED use (e.g., 
age, sex, BMI, and comorbidity score) through linear regression analysis. I understood 
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the rules surrounding research and designed this study accordingly to provide the data of 
interest. I believe I was free of bias in evaluating results of the study.  
Significance 
The significance of the study lay in the possibility of examining the significant 
differences in ED use across different counties in the state of Maryland, and assessing 
how insurance coverage, access to care, cost, and other characteristics related to frequent 
ED use. This research could have significant implication for public health policy. As not 
much is known about the characteristics of ED users in Maryland, the study could fill the 
knowledge gap. In addition, it could inform and assist policy makers in allocating scarce 
resources to bring about a positive social change. This research could assist policy 
makers in allocating scarce resources to support research in CHF and COPD. This would 
in effect assist healthcare providers to focus more on preventive measures in reducing 
CHF and or COPD. Knowledge from this research could potentially assist Medicare and 
Medicaid beneficiaries in making meaningful healthier lifestyle changes such as diet, 
nutrition, exercise, moderation in alcohol consumption, and smoking cessation that have 
the effect of prolonging longevity and minimizing the burden (healthcare cost, financial, 
loss of home, single parenthood) on families and society. Ultimately, the positive effects 
could alleviate the financial burden on the local, state, and federal governments. The 
findings of the study could potentially suggest further reforms to improve primary care 
and reduce ED utilization. Furthermore, geriatric EDs that mainly cater to the needs of 
chronically ill elderly patients have recently emerged as a possible alternative to 
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traditional EDs, and this research could lend support to Medicare pursuing this model of 
care to cater for the most vulnerable population in our society (Hartocollis, 2012). 
Summary 
This chapter outlined the problem of frequent ED visits by Maryland Medicare 
and Medicaid beneficiaries with CHF and COPD, and of the economic burden 
experienced by families, states, and the nation as well as the need for preventive 
measures and treatment of preventive strategies for patients who are Medicare and 
Medicaid beneficiaries. Effective preventive measures of ED service utilization and 
healthcare cost among this vulnerable population were also examined. Rosenblatt et al. 
(2000) found that a PCP who is generalist, as opposed to a specialist, appears to be a 
protective factor along with the patient having high COC with PCPs. Oster and Bindman 
(2005) found that ambulatory care sensitive conditions (ACSC) are chronic diseases for 
which there is wide variation in hospitalization rates and for which better access to and 
quality of primary care is believed to reduce unnecessary hospitalization. Jencks, 
Williams, and Coleman (2009) found that three ACSCs, heart failure, pneumonia, and 
COPD, represented the top three causes of 30-day hospitalizations in Medicare fees for 
service beneficiaries. Kirby, Dennis, Jayasinghe, and Harris (2010) reported that COPD 
and CHF were two of the conditions most strongly associated with frequent readmission 
on the ED use. Ruger et al. (2004) argued that gender also appears to influence ED use 
with women more compared to men. They found that frequent ED users have consistently 
been found to be insured and have greater odds of being covered by Medicare or 
Medicaid than infrequent or nonusers (Ruger et al., 2004).  
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The need for further study in understanding the characteristics of the older 
population in accessing ED in managing their chronic conditions (CHF/COPD) with 
respect to Maryland Medicare and Medicaid beneficiaries closed the knowledge gap and 
helps reduce the economic burden as well. This study design, employed in addressing the 
research, was restricted to the two chronic conditions of CHF and COPD. These two 
high-risk conditions have higher health care resource utilization, costs, and high 30-day 
readmission rates (Aziz et al., 2011; Kociol et al., 2013). The use of physical exercise and 
diet were both studied as preventive measures. The theoretical foundation of the 
epidemiological triad was discussed was to describe the problem of CHF/COPD patients’ 
frequent use of ED in Maryland.  
Chapter 2 includes a literature review that presents further details on the research 
described above. In addition, further background research on the theoretical foundation 
and conceptual framework is presented in more detail in the next chapter. Chapter 3 




Chapter 2: Literature Review 
Introduction 
While frequent ED use among Medicare and Medicaid beneficiaries in Maryland 
is not well understood, findings from related research on other populations provide 
insight that may be relevant to the Medicare and Medicaid population. Pines et al. (2011), 
in a recently literature review and expert consensus, identified several gaps in the public 
health and medical literature on frequent ED use. The major challenge to coherently 
synthesizing results from research conducted to date on frequent ED attendance is the 
lack of a meaningful categorization of frequent users in a given year as well as 
longitudinally across time. The authors call for a more meaningful taxonomy to describe 
ED utilization based not only on frequency but also on patterns, such as long-term, short-
term, and periodic use, admission to the hospital, number of facilities visited, and 
stratification by specific conditions (Mandelberg et al., 2000). Mandelberg et al. (2000) 
observed that the proportional risk of frequent use by the elderly is not well understood as 
studies based on observations of single ED and population survey have low 
representation of older adults. The authors call for interventions focused on patients with 
chronic frequent use, as these patients may have substantial needs that are not being met 
in primary care (Mandelberg et al., 2000). Gruneir et al. (2011) found that lack of studies 
on the effect of proactive health services such as primary care on reducing ED visits is 
the most obvious gap in the research literature. 
Fuda and Immekus (2006) found that in an analysis of claims from all nonfederal, 
acute-care hospitals in Massachusetts, a bimodal distribution in frequent ED use is 
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defined as five or more visits annually with increased prevalence in patients aged 25-44 
and older than 65. They noticed that regression to the mean in frequent users with most 
returning in frequent or nonuse the subsequent year. Cook et al. (2004) observed similar 
trend in a statewide analysis of ED claims from 1996-1998 in Utah finding that only 5% 
of participants were frequent ED users in all 3 years of study. Hunt et al. (2006) made the 
case that frequent ED use should be defined according to the size and impact of the group 
of patients. Their rationale was that persons accounting for a disproportionate share of 
ED incidents would be an appropriate target for intervention. They also emphasized that 
focusing on a group that represents 25% of ED events would likely have a substantive 
impact on the total number of ED visits (Hunt et al., 2006). 
LaCalle and Rabin’s (2010) systematic review concluded that there is no 
generally accepted standard of what constitutes frequent ED use. The identified variable 
definitions ranged from two to 14 visits annually and observed that investigators usually 
weigh the sensitivity of a measure in capturing the population of interest against the 
specificity of defining a group that can be targeted for intervention (LaCalle & Rabin, 
2010). LaCalle and Rabin (2010) advocated for a cut of four or more visits in a calendar 
year, which is commonly used in most literatures. Locker et al. (2007) further supported a 
threshold of four or more visits to classify frequent ED use. They projected a theoretical 
distribution of ED visits to an ED and minor injury unit in the England (LaCalle & Rabin, 
2010). At four visits, the observed frequency plateaued at around 1,000 on a logarithmic 
scale, deviating significantly from the expected distribution, which continued the decline 
(LaCalle & Rabin, 2010). The authors found that 99.99% of chance attenders would be 
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expected to show up in ED less than four times in a calendar year (LaCalle & Rabin, 
2010).  
Oster and Bindman (2003) found that ACSC are chronic diseases for which there 
is wide variation in hospitalization rates and for which better access to and quality of 
primary care is believed to reduce unnecessary hospitalization. Jencks et al. (2009) found 
that three ACSCs in particular – heart failure, pneumonia, and COPD were the top three 
causes of 30-day hospitalizations in Medicare FFS beneficiaries. Kirby et al. (2010) 
reported that COPD and CHF were two of the conditions most strongly associated with 
frequent readmission on to the ED. 
Chapter Overview 
In this section, articles of frequent ED use were reviewed and relevant 
information was synthesized. Ultimately, gaps in the literature on frequent ED was also 
discussed, as well as how this research analysis furthered our understanding of ED use 
among Medicare and Medicaid beneficiaries in the state of Maryland. This research 
attempted to contribute to the literature on frequent ED use in the state of Maryland by 
examining the persistent and frequent ED use among Medicare beneficiaries.  
This work could help identify a population of users that are potentially suited to 
public health intervention. This study could also address an important gap in the current 
research by exploring the importance of primary care at the community and individuals 
level in reducing frequent ED use. The goal of this dissertation was to provide health 
services researchers and policy makers with a better understanding of modifiable factors 
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that affect frequent ED use in order to guide future studies and inform the development of 
targeted interventions and policies.  
To evaluate the problem statement for this study thoroughly, applicable previous 
research literature was reviewed and summarized under Appendix A. Previous literature 
identified as relevant to my research topic was used to support the study while attempting 
to address potential gaps in the literature. 
Literature Search Strategy 
I used Google Scholar search engine, Center for Medicare and Medicaid Services 
database, Walden University Database, and PubMed to identify related articles and 
journals. The key words used in conducting the research include frequent emergency 
department use/visits, emergency room visits, emergency department use by Medicare 
and Medicaid beneficiaries in Maryland, and Medicare and Medicaid beneficiaries with 
CHF and or COPD. Papers published within 6 years were mainly used for the research. 
However, earlier articles that were deemed useful were also reviewed.  
Theoretical Foundation 
Andersen’s Model of Health Behavior  
According to Andersen’s (2008) model of health behavior, utilization of health 
services is determined by chain of predisposing characteristics, enabling resources, and 
need. Need, both perceived and evaluated, represents the proximate determinant of health 
services utilization (Andersen, 2008). However, predisposing factors, such as 
sociodemographic characteristics and health beliefs, place certain individuals at greater 
risk for developing an illness (i.e., need) and enabling resources, such as community 
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resources and access to primary care, influence the seeking of medical services to address 
needs (Andersen, 2008). When need is the primary determinant of health service 
utilization, rather than predisposing characteristics or enabling resources, access to 
services is assumed to be equitable (Andersen, 2008). On the contrary, if predisposing 
characteristics and enabling resources explain more variance in health service utilization, 
then it also suggests inequity in utilization of access and quality (Andersen, 2008). 
Andersen (2008) updated this model to reflect the importance of contextual 
characteristics as well as individual determinants of health service utilization. Contextual 
characteristics can predispose (as in the demographic composition of a community), 
enable (as the supply of medical personnel and facilities), or suggest need for health 
services (as in mortality and morbidity rates; Anderson, 2008). These factors interact with 
individual characteristics, which predispose, enable, or suggest need for health services, 
as discussed in the previous paragraph. The contextual and individual characteristics in 
turn lead to health behavior such as personal health practices (i.e., nutrition and fitness), 
processes of medical care (i.e., physician-patient communication, ordering certain tests, 
or prescriptions), and use of personal health services (e.g., physician and ED visits). 
Ultimately, these factors result in the outcomes of perceived health, evaluated health, and 
consumer satisfaction. 
Andersen’s (2008) Behavioral Model (BM) has been used extensively in studies 
investigating the use of health services (Babitsch, Gohl, & von Lengerke, 2012). The 
studies identified for this review showed that the model has been used in several areas of 
the health care system and in relation to different diseases (Babitsch et al., 2012). The 
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1995 version of the BM was the version most frequently applied by researchers (Babitsch 
et al., 2012). However, the studies showed substantial differences in the variables used. 
The majority of the reviewed studies included age, marital status, gender/sex, education, 
and ethnicity as predisposing factors and income/financial situation, health insurance, and 
having a usual source of care/family doctor as enabling factors (Babitsch et al., 2012). As 
need factors, most of the studies included evaluated health status and self-
reported/perceived health as well as variety of diseases (Babitsch et al., 2012). Although 
associations were found between the main factors examined in the studies and the 
utilization of health care, there was a lack of consistency in these findings (Babitsch et 
al., 2012). 
This study focused on the usage of one type of health services: ED use. The main 
contextual variables of interest will be measures of insurance coverage, at two levels: (a) 
the number of beneficiaries with Medicare coverage who frequent the ED and (b) the 
number of beneficiaries with Medicaid coverage who frequent the ED. Other contextual 
level variables such as case type, cost, sociodemographic composition, and health indices 
of the community were used as controls. Individual level variables relating to 
predisposing characteristics such as race, age, and Medicaid eligibility, and need, such as 
chronic disease diagnoses and HCC scores, were also used as controls to help isolate the 
effects of primary care factors.  
The Epidemiological Triad 
The epidemiological triad model consists of a common model used in public 
health, and it illustrates the relationships among an agent, a host, and the environment 
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(Lilienfeld & Lilienfeld, 1980). This, as used in communicable disease, is basic and 
foundational to all epidemiology (Lilienfeld & Lilienfeld, 1980). However, infectious 
diseases are no longer the leading cause of death in industrialized nations (Lilienfeld & 
Lilienfeld, 1980). As a result, a more advanced model of the triangle of epidemiology has 
been developed. The new model includes all aspects of the communicable disease model 
and updated with the current causes of diseases, conditions, disorders, defects, injury, and 
death reflecting current causes of illness and conditions (Lilienfeld & Lilienfeld, 1980). 
Behavior, lifestyle factors, environmental causes, ecological elements, physical factors, 
and chronic diseases have been accounted for (Lilienfeld & Lilienfeld, 1980). 
The new advanced model of the triangle of epidemiology reflects the behavior, 
lifestyle, and chronic disease issues found in modern times better compared to the first 
version. The advanced model recognizes that disease states and conditions affecting a 
population are complex and that causative factors are many. It gives recognition to the 
fact that many factors and elements contribute to disease in populations.  
Applications of this Model in Ways Similar to this Study 
By the 1960s, extensive studies such as the Framingham Heart Study, the Seven 
Countries Study, and the British Doctors Study, began to identify the leading causes of 
chronic diseases (Foody, Mendys, Liu, & Simpson, 2010). The various researches 
showed the effect of cigarette smoking, poor diet, physical inactivity, and high blood 
pressure to be leading causes of death (Foody et al., 2010). Almost half a century ago, the 
various researches helped identified behavioral causes of chronic diseases afflicting 
humankind (Foody et al., 2010). No researchers established a culprit of death to any 
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particular chronic disease; instead, causes were shown to have contributed to death 
(Remington & Brownson, 2010).  
During and after the 1960s, researchers continued to study the relationship 
between risk factors (e.g., poor diet, lack of exercise, high blood pressure) and major 
chronic diseases (Remington & Brownson, 2010). For example, the diet and heart 
hypothesis was tested in observational studies such as the Framingham Heart Study, a 
prospective cohort study of residents of Framingham, Massachusetts (Foody et al., 2010). 
At the same time, researchers shifted their focus from chronic diseases to the behavioral 
risk factors preceding the diseases. The authors used the results from decades of 
epidemiologic studies to explain that about half of all deaths may be attributed to few risk 
factors (Foody et al., 2010). The research was later updated by Mokdad (as cited in 
Remington & Brownson, 2010). 
In 1974, the Canadian Lalonde Report concluded that the health of a population 
could be considered in four broad elements: human biology, environment, lifestyle, and 
healthcare organization (Remington & Brownson, 2010). The model of the multiple 
determinants of health provides a broad conceptual framework for looking at the factors 
that affect health in a society (Remington & Brownson, 2010). The multidisciplinary 
approach of the model, along with other factors, were found to be accounting for 
differences in health outcomes and the opportunity for prevention (Remington & 
Brownson, 2010).  
Some studies focused on the role of social and economic factors that had high risk 
for chronic disease. Marmot’s research relating to British civil servants vividly portrayed 
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these concepts (Remington & Brownson, 2010). Marmot and other researchers have since 
showed demonstrated that health behaviors alone may not fully explain the risk 
associated with mainly health determinants (Remington & Brownson, 2010). A new field 
of social epidemiology emerged during this same period and became best known for 
identifying the social rise in health, in which health outcome effects exist not only at the 
extremes of high and low levels of education and income but also the ranges in between 
(Berkman & Kawachi, 2000; McGinnis et al., 2002).  
Previous studies have shown the contribution to health outside the environment 
and behavior health (Woolf, Johnson, Phillips, & Philipsen, 2007). These factors include 
socioeconomic position, race/ethnicity, social networks and support, work conditions, 
economic inequality, and social capital (Woolf et al., 2007). These assertions were 
summarized, stating, “The greatest advances in understanding the factors that shape 
population health during the past 20 years has been the identification of social and 
behavioral conditions that influence morbidity, mortality, and functioning” (Remington 
& Brownson, 2010, p. 1). Though there has been a remarkable improvement in chronic 
disease epidemiology and management, there is a lag between scientific knowledge of 
viable chronic disease management and the widespread application to the particular 
population (Remington & Brownson, 2010).  
Rationale for Choice of the Theory 
The proposed research focused on epidemiological dimension as opposed to 
clinical trial. This retrospective cross-sectional study will use administrative data 
(Medicare and Medicaid) in performing the analyses. The three confounding relating to 
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the epidemiological triad model include person, time, and place. The investigative 
analyses of CHF/COPD would be done by controlling for age, sex, race, and 
socioeconomic factors, in relation to frequent ED use among Medicare and Medicaid 
beneficiaries. The place variable that was used in the analysis of the study included the 
State of Maryland, and comparing ED use in relation to CHF and COPD among 
Medicare and Medicaid beneficiaries; this represented an aspect that has been shown 
previously as costly (Agarwal et al., 2012). Time was considered in this study as the 
duration a patient is admitted into a particular hospital and the time beneficiaries are 
afflicted with CHF/COPD, whether it started in the early or later stage in the patient life 
and whether the impact of ED use is affected by such timing factors.  
Conceptual Framework 
The CMS (2012) has been inflicting financial penalties on hospitals with high 
risk-adjusted, 30-day all-cause unplanned readmission rates after an index hospitalization 
for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD; DHHS, 
2014). This policy is an extension of Medicare’s Hospital Readmission Reduction 
Program (HRRP), which seeks to improve quality and reduce costs by creating financial 
incentives for hospitals to prevent readmissions and it is a part of a trend toward 
increased accountability in health care (CMS, 2012). One of the means to improve care 
quality, eliminate waste, and reduce costs, performance measures is an increased use of 
public reporting, pay for performance, and accreditation. All this is an effort to result in a 
benefit for patients (Joint Commission, 2015). 
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The focus was the topic of 30-day hospital readmissions. Among Medicare 
beneficiaries discharged from the hospital in 2005, 17.6% were rehospitalized within 30 
days, resulting in estimated annual expense of $17 billion (MedPAC, 2007). 
Approximately 76% of these patients were rehospitalized for cause potentially due to 
poor quality of care. The report hinted that decreasing avoidable, quality-driven 
readmissions could possibly save $12 billion annually (MedPAC, 2007; Jencks et al., 
2009).  
Literature Review Related to Key Variables and Concepts 
In an effort to reduce ED visits and prevent avoidable hospitalization and 
readmission as well as a means for cost savings, the U. S. Patient Protection and 
Affordable Care Act (ACA) was passed in 2010. Included in this ACA was legislation to 
support the HRRP, an initiative that ties Medicare reimbursement to hospitals with 
patient outcomes (CMS, 2012). CMS began reducing payments by 1%, which eventually 
increased to a full 3% in October 2014, to hospitals with high rates of all-cause 
readmission for three conditions: acute myocardial infraction, congestive heart failure 
(CHF), and pneumonia (DHHS, 2012). Until now, more than 2,000 hospitals have been 
penalized nationwide, resulting in an estimated $280 million in penalties for fiscal year 
2013 (Kaiser Health Network, 2012).  
Since October 2014, CMS has expanded the conditions to include all-cause 
unplanned readmissions after an index hospitalization for AECOPD (DHHS, 2014). In 
the United States, COPD is responsible for more than 1.5 million emergency room visits 
and 725,000 hospital admissions annually, with resulting healthcare costs approaching 
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$60 billion (Mannino et al., 2002). Among patients hospitalized for AECOPD, 34 to 40% 
do not receive recommended therapies, whereas nearly half receive at least one 
inappropriate or potentially harmful therapy (Lindenauer et al., 2006; Mularski, Asch, 
Shrank et al., 2006). Approximately 22.6% of patients discharged after AECOPD have an 
all-cause 30-day readmission, indicating the significant impact to patients, payers, and 
healthcare systems (Jencks et al., 2009; see Appendix A). 
Critique of Method 
Critique of CHF Studies 
This section of the literature review will consist of an analysis of the various study 
designs, methods, and limitations relating to the studies associated with my research. 
Among the studies reviewed, there were differences in the design as well as the methods 
used in analyzing the research materials. According to O’Neil et al. (2010), the results 
indicated that race is a key predictor of preventable hospitalizations among the elderly for 
CHF, hypertension, diabetes, and adult asthma; racial disparities in these hospitalization 
rates are not explained completely by demographic and socioeconomic factors or 
underlying prevalence; and the excess costs from such disparities are substantial. These 
findings suggest that differences may be due to variation in access to primary care, 
quality of care, and physician practice experienced by elderly African Americans 
compared with Whites. 
It was shown that minorities are less likely to have a regular doctor, source of 
care, and medical home. They are also less likely to report getting medical care when 
they need it. Further, it was found that racial disparities in access to care might be at least 
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partly explained by the type and extent of medical services available within communities 
with different racial compositions. The present study indirectly supports this finding, in 
that overall differences were found in ACSC hospitalization rates by geographic areas 
based on the racial composition of elderly residents. At the same time, it was found that 
racial differences persist within geographic, that is, residence location does not explain all 
racial differences suggesting that different racial groups may have different experiences 
in access to and quality of care even when they have the same geographic access to care. 
Biello, Rawlings, Carroll-Scott, Browne, and Ickovics (2010) found that African 
Americans were hospitalized at a significantly younger ages that Whites for all causes, 
chronic conditions, acute conditions, and the following conditions – uncontrolled 
diabetes; bacterial pneumonia; diabetes of the circulatory system such as congestive heart 
failure and hypertension; COPD; and dehydration. Some of the limitations with respect to 
this study include that the data did not allow a determination of whether these were first 
or repeat admissions for ambulatory care-sensitive conditions. Using discharged records 
with incomplete data on SES and comorbid conditions limits the extent to which 
underlying causes can be disentangled. Primary sampling units were not available in the 
public-use files of the NHDS; therefore, generalized linear models could not be 
performed, and robust SEs had to be performed account for the dependence of individuals 
within clusters. Finally, because data were collected using discharge records, missing 
data and measurement error was problematic. 
On the contrary, this study had some strengths, utilizing data from a 
representative national sample of more than 6800 hospital discharges. The focus on 
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ambulatory care-sensitive conditions, which are frequently used measures, can be easily 
replicated. Moreover, this can serve as a common metric through which changes over 
time can be documented. The results of this study highlight the impact that younger age 
at hospitalization may have on the social an economic well-being of individuals and their 
families, through loss of wages, poorer quality of life, and risk for a greater number of 
hospitalizations and severity of illness over the life span. 
Another study of coronary heart disease risk trends, conducted by Kramarow, 
Lubitz, Lentzner, and Gorina (2007), showed an estimated 10-year risk of coronary 
events of an adult aged 45 to 65 years decreased largely despite an increased prevalence 
of obesity, and diabetes. Previous discharge statistics showed ischemic heart disease 
mortality and hospital admission for this population group described during the study 
period. The result for younger adults was similar to the decrease among older CHF group. 
The study found a 31% decrease in risk for older people aged 65 to 74 years in the study 
period. Recent study evidence for the role of decreasing risk factors in reducing coronary 
occurrence and mortality. The finding is similar to earlier studies of heart risk among 
patients with diabetes. It also affirms reports of risk to obesity decline due to treatment of 
risk factors (Ford, 2011).  
Joynt, Orav, and Jha (2011) examined the relationship between volume of patients 
with CHF and clinical processes, outcomes, and costs, and found that patients with CHF 
discharged from hospitals with a higher volume of such patients received higher-quality 
care, on average, and had better outcomes, but at modestly higher cost. These 
relationships were independent of other key hospital characteristics, including teaching 
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status and hospitals size. The strongest effect of volume on outcomes was seen in the 
group of hospitals with the lowest volume. The effects of volume on outcomes seemed to 
diminish beyond 200 to 400 discharges over the study period. The findings suggest that 
the volume-outcome relationship previously observed for procedure-based conditions 
also existed for CHF and may extend more broadly to chronic medical conditions. The 
finding that higher volume was associated with greater inpatient costs is novel and has 
important implications for the health policy debate. 
Limitations to this study include lack of data about the clinicians who cared for 
these patients and could not assess the effect of clinician volume or specialty on 
outcomes. Additionally, because administrative data were used rather than clinical data, 
the authors calculated a nurse-o-patient ratio for each hospital but lacked data on the 
intensity of the nursing care that each patient received. Furthermore, administrative data 
also presents difficulties in accounting for variations in the severity of illness across 
hospitals. Although administrative data are imperfect, they are standardized, validated, 
and increasingly used, even for public reporting. The focus on Medicare patients, though 
these patients make up more than 80% of CHF admissions, the applicability of the 
findings to non-Medicare patients was unclear.  
Critiques of COPD Studies 
The effects of exacerbations frequency of COPD patient may influence quality of 
life as well as overall long-term health outcome (Laurin, Moullec, Bacon, & Lavoie, 
2012). The frequency of episodes could potentially affect overall health care cost of a 
state/nation. Most of the COPD studies reviewed did not touch on subgroup analysis or 
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medication adherence. The researchers observed utilization, cost, and the relationship 
with COPD beneficiaries with chronic bronchitis who have moderate and severe episodes 
within a year regarding health care service use and cost compared to other subgroups 
(Laurin et al., 2012). Patients who experience two or more episodes had higher numbers 
including rate of COPD episodes, PCP visits, as well as COPD associated cost of care.  
The results highlighted that severe conditions have higher utilization and costs 
incurred for each patient. The amount reported under this study approximately could save 
$5125 within a year for COPD patients and $11,599 total costs. These results are similar 
to those reported by previous studies. For example, Yu et al. (2011) observed that health 
care costs increased in parallel with the severity of exacerbations experienced by COPD 
patients. Similarly, as seen in the current study, Yu et al. demonstrated that all-cause 
costs were double for patients with any exacerbation compared with those without any 
exacerbation. However, although similar trends in data were observed in both the study 
by Yu et al. (2011) and the current study, the cost and utilization rates reported by Yu et 
al. were lower compared to those observed in the current study. This may be because Yu 
et al. reported the data quarterly as opposed to annually, or it may be because Yu et al. 
focused on the general COPD patient rather than restricting the study to COPD patients 
with chronic bronchitis. In addition, the difference in data sources and or geographic 
location of the members observed in both Yu et al.’s study and the current study may 
include other contributing factors to cost differences. 
Interestingly, as with the study by Yu et al. (2011), the research reported in the 
study derived from data from a claims database. One of the limitations inherent in using 
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claims data is that clinical measures, such as FEV1, were not available to identify 
baseline severity of patients or to measure outcomes during follow-up. In addition, as 
with all claims data analyses, there is the possibility for error due to missing information 
that was not coded in the database. However, the use of a claims database does provide a 
range and depth of data not necessarily available from other resources. Importantly, 
studies examining the cost of COPD exacerbations in other countries including France 
Canada, and Poland (Pasquale, Sun, Song, Hartnett, & Stemkowski, 2011) reported that 
cost went up because of severe exacerbations, which is similar to this research. Another 
limitation was that a multivariate regression was used to account for the selection bias 
and strengthen the causal inference. This design can only minimize bias affected by 
covariates; it would not minimize bias caused by unmeasured covariates. Hence, no 
causal deduced from the study.  
Dalal et al. (2010) stated that more than 15% of hospital admission of COPD 
patients in 2008 were readmitted within 30–60 days and 17.8% of ED patients had 
frequent ED visit within 30 to 60 days. Other research reported that all-cause readmission 
rate for COPD patients was 22.6% within 30 days and a COPD-related had 38% within 5 
months (Jencks et al., 2009). 
Although Dalal et al. did not assess effect of other related conditions on utilization 
and cost, a number of patients afflicted with comorbidities such as cardiovascular, 
depression and asthma. Having other comorbidities have the effect of high 
hospitalization; for instance, asthmatic and COPD patients have significantly higher 
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respiratory-related costs relating to ER visits compared to COPD alone (Blanchette, 
Dalal, & Mapel, 2012).  
Dalal et al. (2010) observed unadjusted relating to ER visits costs hospital 
admissions. The research has advantages in that costs of treating chronic disease are 
rarely examined from hospital point of view as many studies used administrative data 
with third party payer. The research highlights the cost incurred by hospitals. One of the 
major strength is the larger sample size pertaining to encounter categories.  
A limitation affecting the larger database of inpatient data from 6022 hospitals is 
that unique patients may be identified from the records from a given hospital. Those who 
were readmitted to a different hospital, Dalal et al. (2010) could not evaluate the 
readmission rate. Jencks et al. (2009) found that 24% of Medicare beneficiaries admitted 
to a large hospital for any reason were readmitted to a different facility within 30 days. 
With these limitations, rates of rehospitalization and frequent ED visits are more likely to 
be underestimated. 
In relation to the data, since it contained no clinical data, the authors could not 
assess smoking effect. Although prominent database had all the U. S. regional 
information, it mainly contained southern region data. The findings could not represent 
all the regions in the U.S. Lastly, there are possible missing diagnosis codes and 
procedures in administrative databases.  
Yeatts et al. (2013) study conducted to estimate the burden of COPD-related ED 
visits used a surveillance system that captured 99.5% of ED visits in North Carolina 
provided an excellent opportunity to characterized COPD-related ED visits among a large 
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population. Yeatts et al. found that the COPD-related ED visits rate of 13 per 1,000 
person-years among adults 45 years and older for 2008 to 2009 was higher than a 
national average of 8.72 per 1,000 person-years for 1992 to 2000 for adults greater or 
equal to 25 years of age. Yeatts et al.’s estimate was similar to the 13.16 per 1,000 
person-years annual rate for ages 55 to 64 years (Mannino et al., 2002), but lower 
compared to the study by Rosychuk et al. (2010), which included those greater or equal 
to 55 years of age (25.6/1,000). Differences between Yeatts et al. rates and previous 
estimates are likely influenced by the study’s age distribution, COPD definition, and 
temporal increases in disease. 
Yeatts et al. (2013) related their findings to multiple ED visits were mixed 
compared with previous reports in the U.S. and Canadian Eds. They found patients on 
Medicare or Medicaid or noninsured patients were consistently more likely to have 
subsequent 30-day, 365-day, and multiple COPD ED visits within 365 days. Although 
Tsai, Griswold, Clark, and Camargo (2007) similarly found Medicaid was associated 
with increased COPD ED visits, other public (all Canadian and Medicare) insurance was 
not. Similar to Watson et al. (2004) that found no sex differences for ED visits.  
Another study by DiBonaventura et al. (2012) examined some variables affecting 
working adults 40 to 64 years suffering from COPD in the U.S. Though earlier research 
evaluated impact of COPD on patient’s outcomes, few researchers have focused only on 
workforce. Results indicated that workers who have COPD has significantly lower 
quality of life. The study however, excluded patients under 65 years of age with COPD. 
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The resource utilization was found to be significantly associated with COPD 
conditions. After taking into consideration the demographic and health history variables, 
COPD workers had primary care physician (PCP) visits. COPD workers showed 
significantly higher ER visits and hospital admissions compared to the control group. It 
may be possible that lack of PCP visits will explain patient’s productivity loss. Perhaps, 
the absence of proper management of one’s condition may result in poor outcomes and 
may account for higher rates of ER visits and hospital admissions (DiBonaventura et al., 
2012). 
This study was a cross sectional National Health and Wellness Survey (NHWS) 
so it was reported as associations rather than relationship. Due to self-reported nature of 
the survey, a recall bias may have accounted for unintended errors in the observed 
associations. Most could possibly be ignored to account for COPD diagnosis. Finally, 
though NHWS is demographic representation of the U.S. population, the randomized 
sampling framework was possibly different other than demographics, which may 
influence the size and direction of the relationship observed in the study (DiBonaventura 
et al., 2012). 
Gap Addressed by this Study 
Review of all previous literature that used administrative data and surveys were 
retrospective; others however were randomized controlled studies. While the studies may 
be of interest in establishing association, they may not fully exemplify the characteristics 
of Medicare and Medicaid beneficiaries in Maryland with chronic conditions, specifically 
CHF and COPD, and the impact on ED visits. Limited research was found regarding ED 
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utilization and cost, and no literature was identified that explored the epidemiological 
triad characteristics of person, time, place, and the ways some variables impact CHF and 
COPD preventive measures to curb health care costs among the older population. Several 
of the reviewed researchers showed a relationship between frequent ED visits and CHF 
and COPD. This include the vulnerable population (Dalal et al., 2010; Pasquale et al., 
2012), patients with multiple chronic conditions (Joynt et al., 2011; Mannino et al., 2002; 
O’Neil et al., 2010), and workforce (DiBonaventura et al., 2012). While these researchers 
related CHF and COPD impact on ED visits to utilization and cost, none of the 
researchers conducted their studies in the State of Maryland, and none considered the 
epidemiological triad model’s association with the two chronic conditions. 
Evidence is limited, however, on the effectiveness of intervention for patients 
with a primary diagnosis of Heart failure. No studies specifically focused on Medicare 
and Medicaid beneficiaries ED visits; however, studies about utilization and cost impact 
among HF patients could be found. For example, the study on outpatients with CHF by 
Rosychuk et al. (2010) had too small of a sample size to draw definitive conclusions. 
Therefore, a gap exists for the study of CHF and COPD among Medicare and Medicaid 
beneficiaries who are frequent ED users. Furthermore, no literature was identified that 
observed epidemiological triad in the context of CHF/COPD. My research however will 
focus on filling the gap in the previous studies is intended to help fill a gap on studies of 
association of CHF and COPD patients’ utilization and cost impact in relation to frequent 
ED visits will be evaluated. The epidemiological triad review will be considered in the 
analysis of covariates. 
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 Additionally, some of the current research appears to be from outside the United 
States. Several studies (Agarwal et al., 2012; Miller et al., 2006; Tan et al., 2009) took 
place in Australia and New Zealand; Gershon, Wang, Wilton, Raut, and To (2010) and 
Al-Hazmi et al.’s (2007) studied occurred in Canada, and Shahab, Jarvis, Britton, and 
West (2006) and Soriano et al.’s (2003) studies occurred in England. Those that appear to 
focus on the population in the U.S. included O’Neil et al. (2010) and Biello et al. (2010), 
which were also involved in examining racial disparities in hospitalization for ACSC. 
Others that related to my research focused mainly on the U.S. population in general 
(DiBonaventura et al., 2012; Ford, 2011; Joynt et al., 2011; Kramarow et al., 2007; 
Krumholz et al., 2009; Laurin et al., 2012; Mannino et al., 2002; Pasquale et al., 2010; 
Sandoval et al., 2010; Thorpe, Ogden, & Galactionova, 2010; Tsai et al., 2007; Watson et 
al., 2004; Yeatts et al., 2013; Yu et al., 2011). The other researchers who considered cost 
impact included Blanchette et al. (2012); Dalal et al. (2010); Jencks et al. (2009); Marton 
et al. (2006); and Miller et al.’s (2005) studies. None of the studies reviewed were 
performed in Maryland, which has unique ED characteristics that has impact on 
utilization and cost among Medicare and Medicaid beneficiaries, and outcomes related to 
CHF and COPD interventions. 
In summary, a number of factors have been identified in the existing literature that 
are related to the frequent ED visits among CHF and COPD patients associated with 
utilization and costs of care. CHF and COPD has been demonstrated to be a burden on 
not only the families of the patients but also on the state government and the nation as a 
whole. Most studies were conducted outside of the United States and none of them 
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examined the epidemiological triad model. The research will examine CHF/COPD health 
concerns of the most vulnerable population in Maryland, utilization and cost impact on 
ED visits with consideration of person, place and time burden of the two chronic 
conditions. The retrospective approach, evaluating the utilization and cost impact among 
the Medicare and Medicaid beneficiaries in Maryland, and help identify whether certain 
intervention strategies may help mitigate the excessive cost of care of CHF and COPD 
patients, and the burden on families, and the state of Maryland. 
Summary and Conclusions 
As described in the above analysis, CHF represents the most common cause of 
hospitalization in the Medicare program, and led to nearly 1.4 million hospitalizations 
and $17 billion in total spending in 2007 alone (MPAC, 2009). Despite pharmacologic 
and technical advances in the diagnosis and management of CHF, outcomes in the 
suboptimal, that is, one in 10 patients dies in the first 30 days after hospitalization for 
CHF, and of those who survive, one in four is readmitted (Krumholz et al., 2009). Earlier 
research showed improved health among the elderly population. Though prevalence of 
chronic conditions has risen, life expectancy among elderly have also increased and other 
health conditions have improved (Federal Interagency Forum on Aging-Related Statistics 
[FIFAS], 2010; Kramarow et al., 2007). As the trend indicates, the risk of CHD, it has 
contributed to poor health, disability, and death. The consequence of the aging baby-
boomers could potentially put a strain on the healthcare system and cost but the overall 
effect may depend on the rate and extent of CHD (Ford, 2011; Thorpe et al., 2010). 
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The National health surveys showed an alarming rise of prevalence in obesity for 
the past three decades, current years the rise has plateaued for women. Recently, the 
prevalence of diabetes has risen for the entire population and for some age groups. 
Decrease in physical activity, quality diet and risen caloric intake have been identified as 
the culprit (Caballero, 2007). This has led to expectation that the negative effects on risk 
outcome of the population could diminish or reverse the decrease in CHD mortality and 
stroke in the future. It is interesting to note that several risk factors associated with CHD 
are interrelated and show varying trend (Kramarow et al., 2007).  
Similarly, treatment of exacerbation is burdensome, however, information about 
cost drivers are hard to come by. COPD is known to be a leading cause of mortality and 
morbidity around the globe, which affect approximately 210 million people and account 
for 3 million deaths per year (World Health Organization [WHO], 2009). In the U.S., 
COPD is the third cause of death and amount to 15.4 million physician visits, 1.5 million 
ED visits, and 636,000 hospital admissions annually (Mannino et al., 2002; Pasquale et 
al., 2012). Referencing the national survey data, the overall economic burden of COPD in 
the U.S. in 2007 yielded $42.6 billion, including $26.7 billion in health care expenditures, 
while $11.3 billion was hospital care. The impact of COPD is anticipated to rise, as the 
population becomes older (Dalal et al., 2010).  
COPD is deemed a critical public health issue due to higher incidence and COPD 
associated morbidity and mortality. The COPD condition have a significant health impact 
and a significant economic burden on the nation. The COPD condition was reported for 
5.1% of adults in the U.S. from 2007 to 2009, and the condition was much prevalent 
44 
 
among the elderly and higher for women than men (Pasquale et al., 2012). COPD patients 
ended up having one to three times exacerbation yearly and treatment usually required 
ED visits or hospitalization. This posed a significant financial burden on society. Based 
on target population considered, approximately 25% to 47% of COPD patients 
experienced hospitalization and about 26% had emergency room visits yearly (Dalal et 
al., 2010). Several observational research showed that inpatient care amounts to 52% to 
70% direct medical costs of COPD (Marton et al., 2006; Miller et al., 2005). 




Chapter 3: Research Method 
Introduction 
This retrospective cross sectional study assessed the association between 
COPD/CHF and the frequent ED visits impact on utilization and costs among Maryland 
Medicare and Medicaid beneficiaries. The research identified the characteristics that 
drive CHF/COPD patients to frequent the ED visits and how they influences utilization 
and cost across the various counties in Maryland. Intervention strategies were examined 
to help address preventive measures and to control cost of care for such population. This 
study also reviewed how the Medicare and Medicaid beneficiaries’ access their PCPs as 
well as the epidemiologic triad model (i.e., person, time, and place) of those with 
CHF/COPD conditions among Maryland Medicare and Medicaid beneficiaries.  
This study promoted positive social change by supporting research in CHF and 
COPD to assist healthcare providers in focusing more on preventive measures in reducing 
CHF and COPD. The study examined how insurance coverage, access to care, cost, 
location (counties), and other characteristic s are related to significant differences in ED 
use in the state of Maryland Medicare and Medicaid general population. This section of 
the dissertation proposal describes the study variables, confounders, study design, 
research questions, hypotheses sampling procedure, research construct, sample size, data 
analyses, and comments on threat to validity. 
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Research Design and Rationale 
A retrospective cross sectional study design for this research used the 2010 
through 2012 Medicare Administrative Claims Data in CCW to identify individuals with 
CHF and COPD, classification of Medicare-Medicaid eligibility (MME) type, and 
calculation of cost and utilization statistics. Analysis was limited to individuals identified 
as FFS Medicare and Medicaid due to the unavailability of managed care data in the 
CCW and MMLEADS. The MMLEADS is a collection of data files of annual person-
level and service-level analytic files designed to serve as a tool for improving the care for 
Medicare and Medicaid enrollees (Buccaneer, 2011). The conditions data file provides 
information for the 27 CCW conditions developed to enhance research of Medicare-
Medicaid enrollees (Buccaneer, 2011). Integrated Medicare and Medicaid data available 
in the MMLEADS from the CCW allows for research of physical conditions, eligibility, 
enrollment, cost, and utilization of Medicare-Medicaid beneficiaries (Buccaneer, 2011; 
ccwdata.org).  
This is a retrospective cross-sectional study. The research was also designed as an 
epidemiological model: person, time, and place. The observational retrospective design 
allowed for evaluation of the ED utilization and the cost burden on families, states, the 
nation, as well as the day-to-day operations in an acute care setting. A quantitative 
method analyses was used to evaluate outcomes of Medicare and Medicaid beneficiaries 
with CHF/COPD who frequent ED within the 2-year study period. This research assessed 
ED utilization and the cost burden on families, states, and the nation as a whole. A 
sizeable portion of the literature reviewed was prospective case-control studies. Though 
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retrospective design may not have the robust internal validity of a randomized controlled 
trial (RCT), it does have the advantage of greater external validity. It may also not be 
generally applicable beyond the study population. The study sought to yield applicable 
results that could potentially be useful to other chronic conditions other than CHF and 
COPD. Furthermore, the study design has an advantage that includes predicting acute 
care hospitals to inform lawmakers on healthcare cost. 
Methodology  
Population 
Target population for this study comprised of Medicare and Medicaid 
beneficiaries 65 years and older diagnosed with CHF and or COPD who are also a 
frequent ED user. The study specifically focused on these beneficiaries in the state of 
Maryland. Medicare and Medicaid beneficiaries who are continuously enrolled in fee-for-
service (FFS) Medicare Part A and B from 2010 to 2012 were examined. Preliminary 
sample of beneficiaries eligible for inclusion for this study in the CCW 100% file is 
approximately 10 million, and a subsample of those with CHF and or COPD related to 
the state of Maryland was extracted and analyzed.  
Sampling and Sampling Procedures 
Using the associated data for the specific conditions (CHF and COPD), related 
ER visit and utilization de-identified data were extracted from the CCW using SPSS for 
the required analysis. No informed consent was needed as the collected data has already 
been cleared (Buccaneer, 2011). The ICD-9-CM’s 14,000 plus diagnosis codes and 3,900 
procedure codes are aggregated into a smaller number of clinically meaningful categories 
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that are easier to analyze and interpret (Elixhauser, Steiner, & Palmer, 2012). A high-
level categories of relevant chronic conditions were created based on clinical similarity 
and include as dichotomous 0/1 variables in the analysis. In addition, for the analysis of 
the beneficiaries with CHF and COPD, an index measure of comorbidities was created. 
The CCW files internal to CMS also included hospice claims and minimum data 
set (MDS) assessment data linked by the unique beneficiary ID. These files were used to 
flag individuals who receive hospice care or reside in a nursing home at any point during 
the study’s period. HCC scores were also be used to control for patient acuity. HCC 
scores measured the predicted utilization based on a system developed by CMS for risk 
adjustment in reimbursement to managed care plans (Pope et al., 2004). HCC scores were 
tracked internally at CMS and were matched to beneficiaries in the CCW using the 
unique beneficiary ID. 
A 100% sample of the CCW, which includes approximately 10 million current 
Medicare beneficiaries in any given calendar year, was analyzed for this study. CMS, in 
partnership with Buccaneer Computing and Software Services, launched the CCW in 
2005 as a means of linking claims by beneficiary across the continuum of care. 
(Buccaneer, 2011). Using a unique beneficiary identification number, information 
regarding inpatient, outpatient, skilled nursing facility, home health, hospice, and Part D 
prescription drug use may be linked to demographic and assessment data for a particular 
beneficiary (Buccaneer, 2011). The CCW only included administrative claims for 
beneficiaries enrolled in FFS Medicare; however, encounter data for beneficiaries in MA 
managed care plans are maintained by private health plans (Buccaneer, 2011).  
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The study sample for the research questions consisted of Medicare beneficiaries 
continuously enrolled in FFS Medicare Parts A and B from 2010-2012. Exclusion criteria 
included enrollment in a MA plan, disenrollment from Medicare Part A or B, and death 
during the study period. To separate ED services related to end-of-life care, beneficiaries 
were excluded from the initial analysis if they died in the first 6 months of 2013. Based 
on a preliminary sample creation exercise, the number of beneficiaries eligible for 
inclusion for this study in the CCW 100% files was approximately 10 million. A 
subsample of beneficiaries with chronic disease indicators for the ACSC of interest (CHF 
and COPD) specific to state of Maryland was constructed. Finally, the beneficiaries 
excluded from the initial analysis for dying between 2011 and mid 2013 were analyzed 
separately and to compare ED use between those with and without hospice benefits.  
Sample Size Calculations  
Sample size will be extrapolated using SPSS from the 100% Medicare sample 
from 2010, 2011, and 2012 data. These sample sizes were precalculated for each state 
based on the available information. This study focuses on state of Maryland and as such, 
the sample size was extracted from the 10 million-sample size for the Medicare Medicaid 
population. Sample size analysis was conducted for each of the dependent variables as 
specified by Buccaneer (2011) associated with the ED visits, as it relates to CHF and 
COPD, to give a power of 80% to 95% two-sided confidence interval. 
Power Analysis 
I used G*Power, which is a free power analysis program, for a variety of 
statistical tests in computing the sample size and the power calculation. The latest version 
50 
 
3.1 presents extensions and improvements of the version introduced by Faul, Erdfelder, 
Lang, and Buchner (2007) in the domain of correlation and regression analyses. The 
specific model used in performing the power calculation is position regression yielding a 
minimum sample size of 972 for the study, given alpha of 0.05, a statistical power of 
more than 80%, and an effect size strong enough due to the potential higher anticipated 




Figure 2. Medicare and Medicaid beneficiaries’ analysis.  
 Due to the serious extreme cases of ED visits compared to others, I found the 
poisson regression as an appropriate model to conduct this study. The Poisson 
distribution arises when conducting a number of events across time or over an area (Faul 
et al., 2007). The counts are usually represented as a rate, such as number of ED visits per 
year due to CHF/COPD, or the number of ED visits per particular state (Faul et al., 
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2007). The specified region could take the form of length of time, an area, a volume, or a 
period (Faul et al., 2007). It is important to note that during the analysis, logistic 
regression, and Chi-Square were employed where appropriate. 
Operationalization for the Variables 
Measures – Independent Variables 
The independent variables for the study included supply/availability of PCPs the 
state of Maryland attending to the Medicare and Medicaid population; COC of the 
beneficiaries; frequency of the ED visits by the beneficiaries with CHF and COPD; 
season; service utilization and cost; rate of admission to the hospital, or release from the 
hospital. These variables were assessed using Poison regression, Chi-Square statistics, 
logistic regression, and multiple linear regression where appropriate. 
At the contextual level, predisposing characteristics were measured using the 
Dartmouth Atlas of Health Care (2012) and the Area Resource File (ARF). The 
Dartmouth Atlas Project is an ongoing effort to document geographic variations in 
medical resources and outcomes in the U.S. using Medicare data (Faul et al., 2007). The 
institute provides free, downloadable reports of physician supply and other relevant 
variables at the national, regional, and local level (Faul et al., 2007). Primary Care 
Service Areas (PCSAs) include 6,542 small areas, defined by Dartmouth (2012), as 
aggregating ZIP areas to reflect Medicare patient travel to primary care providers. PCSA 
level variables occurred wherever possible. The Dartmouth Atlas contains measures for 
the percent of African-Americans and percent of elderly at the PCSA level, which were 
both explored as contextual level predisposing characteristics.  
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The ARF, which is maintained by the Health and Resources Services 
Administration (HRSA), compiles data from several sources, including the US Census 
and medical professional associations to produce 6000 variables at the state level 
(Healthcare Cost and Utilization Project [HCUP], 2012). The ARF describes each state as 
it relates to environmental, economic, public health indicators, and healthcare resource 
availability. To control for other predisposing characteristics that may influence ED use, 
the percent of the population with less than a high school education, unemployment rate, 
and rural/urban status was examined at the state level, consistent with previous research 
(Probst, Laditka, & Laditka, 2009).  
At the individual level, the Beneficiary Summary File of the CCW included 
sociodemographic and clinical indicators of interest to ED use such as beneficiaries’ age 
at the end of the reference year, gender, race, and chronic disease diagnoses (CHF and 
COPD). The Research Triangle Institute (RTI) race code indicated racial categories 
because prior research has demonstrated that it is better able to capture Hispanic ethnicity 
(Frank, 2015). There was no income information in the CCW; however, the Beneficiary 
Summary File did contain a variable indicating the number of months in the year that a 
member was enrolled in Medicaid (Frank, 2015). Any beneficiary with at least 1 month 
of Medicaid enrollment during 2010 was considered as Medicaid eligible, which was 
used as a proxy for poverty status. 
Measures: Dependent Variables 
Congestive heart failure. Medicare and Medicaid beneficiaries with CHF must 
have at least one inpatient or Part B (institutional or noninstitutional) claims with a heart 
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failure code in any position during the 2-year reference period. The CCW’s chronic 
condition flags require beneficiaries to satisfy both claims criteria (a minimum 
number/type of claims that have the proper diagnosis of FFS Part A and B) of coverage 
during the entire specified time. The CCW’s criteria were developed after reviewing 
validated algorithms from the research literature and criteria used by other federal data 
sources (ccwdata.org, 2015). 
Chronic obstructive pulmonary disease. Medicare and Medicaid beneficiaries 
with COPD must have at least one inpatient, SNF, or home health claim, or two Part B 
(institutional or non-institutional) claims with a COPD code in any position during the 1-
year reference period. The CCW’s chronic condition flags require beneficiaries to satisfy 
both claims criteria (a minimum number/type of claims that have the proper diagnosis 
code and occurred within a specified time) and coverage criteria (FFS Part A and Part B 
coverage during the entire specified time). This variable was also reviewed, validated, 
from research literature and criteria used by other federal data sources (ccwdata.org, 
2015). 
Information regarding services delivered in the E.D may appear in three separate 
files, as follows. Medicare beneficiaries, seen in the emergency room and admitted to the 
hospital, are represented in the inpatient records; whereas, those seen in the ED, but 
released, are represented in the outpatient file (Merriman & Caldwell, 2003). Additional 
ED service was not captured in the inpatient and outpatient files, such as charges for 
physicians not employed by a hospital and laboratory services, which were documented 
in the carrier files instead (Merriman & Caldwell, 2003). Inpatient and outpatient ED 
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claims can be identified by Revenue Center Codes 0450-0459 (Merriman & Caldwell, 
2003). ED claims in the Carrier files are designated by Place of Service Code 23 or 
HCPCS codes 99281-99285, which represent evaluation and management (E&M) codes 
for ED services (Merriman & Caldwell, 2003). Frequent ED use referred to four or more 
visits in a calendar year.  
Frequent users were further categorized by the persistence of frequent use over 
the 2-year study period. Consistent with the rationale provided by Mandelberg et al. 
(2000), beneficiaries with four or more visits in 2 or more consecutive years were 
considered “persistent” frequent ED users. Beneficiaries with 1 year of frequent ED use 
were considered “episodic” frequent ED users.  
A further differentiation among ED users was made regarding admission to the 
hospital and reason for the ED visits. Each ED visit was classified by two binary 
variables for whether or not the visit resulted in a hospital admission and whether or not 
the visit was for an ACSC. These determinations were based on whether the ED carrier 
claim has a corresponding inpatient claim and the claim primary diagnostic code, 
respectively. At the beneficiary level, this information was aggregated into a continuous 
variable indicating the percentage of visits that result in hospitalization and the 
percentage of visits that were for ACSC. 
Medicare FFS utilization and payment data. The Medicare/Medicaid eligibility 
status for all members of the study population is available in the Beneficiary/Enrollee 
File. There is a single row of data for each unique person in the beneficiary fil, even if the 
person was enrolled in Medicaid in more than one state during the year. The Beneficiary 
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File includes detailed enrollment information, as well as descriptive information (e.g., 
demographic and summary use and payment variables).  
As mentioned earlier, an adaptation with ICD-9 codes was used for this study. 
The constructs in CCW to be used for this study relating to Medicare-Medicaid enrollees 
has all the utilization and payments variables within the Beneficiary File. In this file, 
many of useful payment and service use information has already been aggregated by 
month and year for ease of use. 
Data Analysis Plan 
SPSS was used for the analyses. The administrative claims data that was used for 
this study had already been cleaned and screened. Therefore, the claims data did not need 
further scrutiny. Provider submit Medicare claims to Medicare Administrative 
Contractors (MACs) for payment processing. All valid claims were uploaded to CMS 
National Claims History (NCH). Then, the NCH files represented the original source data 
for all CMS claims files and contained all transactional claims data. The CCW 
downloaded files from the NCH and extracted the final action claims data (i.e., the final 
reconciled version) to create the SPSS analytic files related to Medicare services cost and 
utilization (Buccaneer, 2011). Medicare/Medicaid administrative claims data, specific to 
state of Maryland beneficiaries with either CHF or COPD who frequent ED, was tested 
against the following research questions and hypotheses: 
RQ1. Is the primary care provider (PCP) supply in the State of Maryland 
associated with frequent ED use among Maryland Medicare and Medicaid beneficiaries 
who have either CHF or COPD? 
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H01: Increased ratios of PCP to State of Maryland Medicare and Medicaid 
beneficiaries with either CHF or COPD will have no significant 
relationship with number of ER visits by beneficiaries, while controlling 
for age, gender, and race. 
HA1: Increased ratios of PCP to State of Maryland Medicare and Medicaid 
beneficiaries with either CHF or COPD will have a significant relationship 
with number of ER visits by beneficiaries, while controlling for age, 
gender, and race. 
RQ2. Is frequent ED use associated with end of life for Maryland Medicare and 
Medicaid beneficiaries with either CHF or COPD who die during the study? 
H02: Increased number of visits to the ER will not have a significant 
relationship with death among Maryland Medicare and Medicaid 
beneficiaries with either CHF or COPD while controlling for age, gender, 
and race.  
HA2: Increased number of visits to the ER will have a significant 
relationship with death among Maryland Medicare and Medicaid 
beneficiaries with either CHF or COPD while controlling for age, gender, 
and race.  
Description of Data Analysis Plan  
An exploratory data analysis was used to examine the distribution of ED visits as 
a count outcome and as a categorical outcome. Histograms displayed the frequency of ED 
counts from zero to the highest count, and bar graphs will display the distribution of 
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Medicare beneficiaries among the four ED categories of non-, infrequent, and episodic 
frequent and persistent frequent users. A descriptive correlational design explored 
comparisons among the four categories of ED users using chi-squared statistics for 
categorical variables and multiple linear regression for continuous variables. Tables were 
created to display the relative values of the variables along with p-values to indicate 
statistical significance. Relevant comparisons among the four ED categories will include: 
 Mean age, percent over 65 and under 65 
 Percent Medicare/Medicaid eligible 
 Mean primary care physician supply/1,000, percent high, medium and low 
supply 
 Percentage of visits resulting in hospitalization 
 Percentage of visits for ACSC (CHF and COPD) 
The research analysis also included a series of univariate multinomial logistic 
regression models to test univariate relationships between the categorical outcome of ED 
use and the independent variables. All independent variables, with a statistically 
significant association with ED use, were included in a multivariate multinomial model. 
Finally, multivariate multinomial logistic regression was used to determine the 
relative risk ratio of being an infrequent, episodic frequent, and persistent frequent ED 
user compared to a non-user. The multinomial logistic regression model was an extension 
of the simple logistic regression model for dichotomous dependent variables that applies 
to discrete, nominal, and unordered poltytomous dependent variables (Kwak & Clayton-
Matthews, 2002). Unlike ordinal logistic regression models, multinomial models do not 
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assume proportional odds for being in each category higher than the base category and 
instead estimate separate equations for each category compared to the base category 
(Weng & Barner, 2005). As in the case of the simple logistic regression, maximum 
likelihood estimation (MLE) is used as the normality assumption of ordinary least 
squared (OLS) regression is violated (Weng & Barner, 2005). Wald tests were used to 
test the significance of regression coefficients (Kwak & Clayton-Matthews, 2002).  
One assumption of multinomial logistic regression models is that the error terms 
are independent across individuals and equations. Another key assumption is that of the 
Independence of Irrelevant Alternatives (IIA), which posited that the inclusion or 
exclusion of one category should not affect the relative odds of any other category. To 
test this assumption, I performed a Hausmann test, which compared the estimated 
coefficients of the unconstrained model with all dependent categories to the estimated 
coefficients of various constrained models that exclude one category. If the results did not 
support IIA, I would have used a probit model that allows for flexibility in this 
assumption. Results were reported in terms of relative risk ratios for being in each 
category compared to the index category of no ED use.  
Threats to Validity 
Threats to External Validity 
There are several advantages in using the administrative claims data in CCW, 
including that the results from this study were applicable to the majority of elderly men 
and women in America. There were some limitations to working with the CCW. First, it 
only represented fee-for-service Medicare enrollees, thus one cannot draw conclusions 
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about beneficiaries in MA plans (Buccaneer, 2011). However, only 20% of Medicare 
enrollees were in MA plans in 2010, thus CCW still captured the vast majority of the 
Medicare population (Global Initiative for Chronic Obstructive Pulmonary Disease 
[GOLD], 2010). Therefore, the conclusions I drew remained generalizable to 
beneficiaries enrolled in traditional Medicare, and the study still had strong external 
validity.  
Threats to Internal Validity 
 One major threat to internal validity of my approach to studying frequent ED use 
includes that using administrative claims data precluded examination of critical aspects of 
access to care and quality of care, including clinical measures, such as blood pressure, 
measures of patient functioning, or patient-provider communication. For instance, I could 
not gauge care coordination among medical providers, which obviously represented an 
important aspect of managing ACSCs. Without self-reported information from patients 
and providers, I could not explore certain factors that might be relevant to predicting ED 
use, such as ease of getting an appointment with a primary care provider and satisfaction 
with primary care providers.    
Threats to Construct or Statistical Conclusion Validity 
To avoid threats to statistical conclusion validity, I studied frequent ED use over a 
longer period, specifically 2 years. This allowed for a more definitive and practical 
classification of users by persistence of use and concentration of ED use within a given 
year. Due to the large sample size of the Medicare and Medicaid population, there was no 
threat to the statistical power resulting larger sample is not identified.  
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Another threat to validity may occur if statistical analyses are performed outside 
the framework of the statistical test, for instance, abnormality of error distribution or 
nonlinear relational linear regression. For the purpose of this study, all appropriate 
assumptions tied to the frequent ED use in the CCW administrative data were applied to 
avoid invalidity of statistical conclusion. Correspondingly, using two case studies (CHF 
and COPD) helped reduce any threat to validity. It is important to note that the CMS 
administrative claims data in CCW have been thoroughly cleaned and vetted for research 
purposes (Buccaneer, 2011) to prevent any distortions in the CCW data.  
Ethical Procedures 
This study went through the approval process of the Walden University 
Institutional Review Board (IRB) paving the way for data collection and analyses of the 
study. With respect to using the CCW in accessing the Medicare Administrative data, I 
already had access in using the data as an employee for research purposes, and I did not 
anticipate any issues in conducting the research and performing any related analyses. 
Prior to this, I was cleared and certified for CMS’ privacy and HIPAA regulations. I 
followed all HIPAA regulations governing the use of the Medicare Medicaid Claims 
data. If any ethical questions arose, I intended to consult with the school IRB and the 
agency ethics committee as needed.  
Summary 
In summary, this retrospective study with quantitative analysis of the relationship 
between Medicare population with chronic CHF and COPD and frequent ED visits. The 
impact on ED utilization and cost was examined to ascertain the burden on families, 
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hospitals, and the state of Maryland. I analyzed using linear regression, and two tailed t-
tests to examine the distribution of ED visits. A descriptive correlational design was 
compared among the four categories of ED users using chi-squared statistics for 
categorical variables. Charts and tables were created to illustrate the relative values of the 
variables in conjunction with p-values to show statistical significance of this study. 
Including variables relevant to place, time, and place would render the epidemiological 
analyses as an effective approach to care and wellbeing of Medicare and Medicaid 
beneficiaries with diagnosis of heart failure and congestive obstructive pulmonary 




Chapter 4: Results 
Introduction 
 The purpose of this study is to examine key characteristics of frequent ED visits 
and used administrative claims data to assess utilization and cost for Medicare and 
Medicaid enrollees that were identified as having either CHF or COPD. This was done 
using ICD 9 Codes – primary and secondary diagnostic code (see Appendix 1). 
Specifically, administrative claims data for the State of Maryland was used, focusing on 
beneficiaries with either CHF or COPD who visited ER in the years 2010, 2011 and 
2012. 
 This chapter will first present data cleaning and preprocessing, then summary 
statistics of the data. Next, data analysis using GEE’s will be presented to answer both of 
the research questions and the results discussed. Finally, a summary will conclude the 
chapter.  
Data Cleaning and Preprocessing 
The initial sample size was 33,174. Some subjects changed age, gender and race 
through the years. It was assumed that the age, gender and race reported in 2010 was the 
correct age, gender and race for data analysis purposes and all other demographic data 
was removed from the analysis. There was also significant amounts of missing data 
regarding if a patient had made an ER claim, visited the ER or payment was made that 
year. This missing data was assumed to be 0 throughout. Finally some patients had 
missing age, race or dead status data. These patients were removed from analysis. This 
left a dataset of 14,118 for analysis. Finally, to ensure continuity of dead status, data from 
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patients that have died was removed from the following years. 1,335 subjects died during 
2010 and their data was removed from subsequent years and an additional 1,085 subjects 
died in 2011 and their data was removed from 2012. All data cleaning was conducted in 
R 3.1.2. 
Data Analysis 
Summary statistics of continuous variables are presented in Table 1. The average 
age of subjects included in the study was 79.63, and the average number of ER visits for 

















Table 1.  
Summary Statistics of Age, ER Visits, ER Claims and Payments for the years 2010, 2011 
and 2012 for all COPD and CHF patients.  
Variable  Statistics 2010 2011 2012 
Age Mean  79.63 - - 
 Minimum  65 - - 
 Maximum 110 - - 
 Standard 
Deviation 
8.84 - - 
ER Visits Mean 1.52 1.46 1.50 
 Minimum 1 1 1 
 Maximum 20 11 12 
 Standard 
Deviation 
0.43 0.35 0.37 
 Total Visits 2332 1797 1551 
ER Claims Mean  0.10 0.08 0.07 
 Minimum  0 0 0 
 Maximum 20 11 12 
 Standard 
Deviation 
0.35 0.00 0.00 
Payment 
Amounts 
Mean 193.85 182.42 189.49 
 Minimum 0.00 0.00 0.00 
 Maximum 2565.33 1264.86 1560.21 
 Standard 
Deviation 
6921.74 5862.90 4194.59 
 Total Claims ($) 297954.50 224924.00 196319.00 
Summary statistics of categorical variables are presented in Table 2. Most 
subjects were female (70.8%) and white (46.6%). The death rates for 2010, 2011 and 
2012 were 9.50%, 7.78% and 12.00% respectively. Many racial categories had only a few 
subjects in each, so for the purposes of analysis they were combined into White (n = 
6573), Black (n = 5240) and Other (n = 2305) which included all other racial categories 
including unknowns. Many subjects had both COPD and CHF, subjects with both 




Summary Statistics of Gender, Race and Death for 2010, 2011 and 2012 for all COPD 
and CHF patients.  
  2010  2011  2012  
Variable Level Count Percentage Count Percentage Count Percentage 
Gender Male 4118 29.2 - - - - 
 Female 10000 70.8 - - - - 
 Total 14118 100.0 - - - - 
Age Under 70 2871 20.3 - - - - 
 71-89 9135 64.7 - - - - 
 Over 90 2112 15.0 - - - - 
 Total 14118 100.0 - - - - 
Race White 6573 46.6 - - - - 
 Black 5240 37.1 - - - - 
 Other 2305 16.3 - - - - 
 Total 14118 100.0 - - - - 
Died No 12783 90.50 11698 92.22 10294 88.00 
 Yes 1335 9.50 1085 7.78 1404 12.00 
 Total 14118 100.0 12783 100.0 11698 100.0 
 Admitted to 
Hospital 
753 - 717 - 798 - 
Disease COPD 3034 21.5 2578 20.1 2225 19.0 
 CHF 6064 42.9 5248 41.0 4521 38.6 
 Both 5020 35.6 4957 38.7 4952 42.3 
 Total 14118 100.0 12783 100.0 11698 100.0 
Research Question 1. 
Research Question 1 asked: Is the primary care provider (PCP) supply in the State 
of Maryland associated with frequent ED use among Maryland Medicare and Medicaid 
beneficiaries who have either CHF or COPD?  
H01: Increased ratios of PCP to State of Maryland Medicare and Medicaid 
beneficiaries with either CHF or COPD will have no significant relationship with number 
of ER visits by beneficiaries, while controlling for age, gender and race. 
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HA1: Increased ratios of PCP to State of Maryland Medicare and Medicaid 
beneficiaries with either CHF or COPD will have a significant relationship with number 
of ER visits by beneficiaries, while controlling for age, gender and race. 
The total number of PCP providers (see Appendix 2) in Maryland was 5,622,987 
for 2010, 5,699,640 for 2011 and 5,701,628 for 2012. PCP was converted to number of 
providers per CHF or COPD patient (33,174 from unreduced dataset), giving 169.49 PCP 
per CHF or COPD patient for 2010, 171.81 for 2011 and 171.87 for 2012. It should be 
noted that these definitions did not include nurse practitioners, physician’s assistants and 
online/telehealth professionals which could affect the outcomes of this analysis. 
Summary data on the number of ER visits for each independent variable is 
presented in Table 3. On average, males had more ER visits (7 per 100 individuals) in a 
given year than females (6 per 100 individuals) and subjects who identify as white also 
have the highest average of ER visits (7 per 100 individuals) in a given year for any racial 
category. Under 70’s also had the highest average of ER visits out of any age category 
(10 per 100 individuals), and finally 2010 which had the lowest ratio of PCP to CHF and 
COPD patients had the highest average number of ER visits (8 per 100 individuals). 
There were no obvious differences in mean number of ER visits for patients with and 
without CHF and COPD, although subjects without COPD had the highest mean ER 






Table 3.  
Summary Statistics for ER Visits for each Independent Variable.  
Independent Variable Level Mean ER Visits per 
100 
Std Deviation ER Visits 
per 100 
Gender Male 7 44.7 
 Female 6 36.6 
Race White 7 41.1 
 Black  6 37.9 
 Other 5 35.4 
Age Under 70 10 49.2 
 71-89 6 36.8 
 Over 90 5 34.1 
PCP Ratio 169.49 (2010) 8 43.1 
 171.81 (2011) 6 35.8 
 171.87 (2012) 6 37.0 
CHF No 8 38.6 
 Yes 8 43.9 
COPD No 9 46.3 
 Yes 8 40.0 
This research questions was answered using a Generalized Estimating Equation 
with Poisson log-linear distribution and robust variance estimates (Williams 2000) to 
account for repeated measurements by subject through the years. A model was fitted that 
included ER visit count as the dependent variable, total number of PCP providers as the 
independent variable and that included age, race, gender and COPD or CHF status as 
confounding variables.  The model that was developed included separate parameters for 
COPD status and CHF status. This type of model assumes that the effect of COPD and 
CHF on number of ER visits is additive when a subject has both.  A correlation matrix 
with an exchangeable structure was used. Type I tests for model effects using Wald Chi-
Square tests (Deddens et al. 1998) are presented for the model in Table 4. Based on the 
significant effect of PCP ratio on number of ER visits, we accept the alternative 
69 
 
hypothesis and also conclude that the confounding variables of gender, age, race and 
COPD status are significant. To determine the strength of the effect, the model 
parameters were examined. 
Table 4.  
Significance of Variables for Research Question 1.  
Variable Wald Chi Square df P value 
Intercept 5705.59 1 < 0.001 
PCP Ratio 6.076 1 0.01 
Gender 5.499 1 0.02 
Age (categorical) 52.85 2 < 0.001 
Race (categorical) 6.802 2 0.03 
CHF 1.522 1 0.22 
COPD 3.850 1 0.05 
The model developed to answer question 1 has the following formula: 
Vij ~ Poisson (Yij) 
Log(Yij) = β0 + β1 gi + β2 xi + β3 zi + β4 pj + β5wi + β6bi + β7hi + β8ci + εij 
where Vij is the number of visits for subject i at year j is Vij, gi is equal to 1 if 
subject i is male, 0 otherwise, pj is the ratio of primary care providers for year j, xi is 
equal to 1 if the subject is aged 70 or under, 0 otherwise, zi is equal to 1 if the subject is 
aged between 71 and 89, 0 otherwise, wj is equal to 1 if the subject is white, 0 otherwise, 
and bj is equal to 1 if the subject is black, 0 otherwise. hi is equal to 1 is the subject does 
not have CHF and ci is equal to 1 if the subject does not have COPD, 0 otherwise for 
both. εij is the error term for subject i in year j. Parameter estimates, standard errors and 
significance are presented in Table 5.  
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PCP ratio was found to have a significant relationship with number of ER visits, 
where an increase of PCP ratio by 1 increases ER visits by 3%. The confounding 
variables of gender, age race and COPD status were also found to have a significant 
relationship with number of ER visits. Being male increased the number of ER visits by 
9% compared to being female, and not having COPD increases ER visits by 11% 
compared to having COPD. Being aged below 70 increased ER visits by .76 compared to 
being aged over 90, and being aged between 71-89 increased ER visits by .10 compared 
to being aged over 90. Finally, being white increased ER visits by .29 compared to being 
in the ‘other’ racial category, and being black increased ER visits by .25 compared to 
being in the ‘other’ racial category.  
Table 5.  
Parameter Estimates.  
Parameter β Std Error E^ β Wald Stat Df P value 
Intercept (β0) -9.487 3.24 0.00 8.589 1 0.003 
PCP Ratio (β4) 0.03 0.01 1.03 4.019 1 0.04 
Gender = Male (β1) 0.09 0.07 1.09 1.899 1 0.17 
Gender = Female Baseline 
Age below 70 (β2) 0.57 0.11 1.76 24.486 1 < 0.001 
Age between 71-89 (β3) 0.10 0.10 1.10 1.046 1 0.03 
Age above 90  Baseline  
Race White (β5) 0.26 0.10 1.29 6.396 1 0.01 
Race Black (β6) 0.23 0.10 1.25 5.206 1 0.02 
Race Other  Baseline 
Does not have CHF (β7) -0.006 0.06 0.99 0.010 1 0.92 
Has CHF Baseline 
Does not have COPD (β8) 0.11 0.05 1.11 3.850 1 0.05 
Has COPD Baseline 
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Research Question 2 
Research Question 2 asked: Is frequent ED use associated with end of life for 
Maryland Medicare and Medicaid beneficiaries with either CHF or COPD who die 
during the study? 
H02: Increased number of visits to the ER will not have a significant relationship 
with death among Maryland Medicare and Medicaid beneficiaries with either CHF or 
COPD while controlling for age, gender and race.  
HA2: Increased number of visits to the ER will have a significant relationship with 
death among Maryland Medicare and Medicaid beneficiaries with either CHF or COPD 
while controlling for age, gender and race.  
Summary statistics of deaths for each categorical variable are presented in Table 
6. The large total counts are due to each subject having repeated measurements over 3 
years, hence totals are three times larger than those presented in Tables 1 and 2. Males 
and females had comparable death frequencies (11.1% for each), but subjects who 
identified as white had a higher frequency of deaths than other racial categories (12.6%). 
Subjects who were aged under 70 had the lowest frequency of death out of all the age 
categories (7.0%). Death rates for subjects with and without CHF were similar (10.0% 
and 9.7% respectively), and death rates for subjects with and without COPD were also 
similar (10.0% and 9.9% respectively).  
The mean number of ER visits for subjects who did not die was 0.07 (standard 
deviation = 0.39) and the mean number of ER visits for subjects who did die was 0.06 
















Gender Male 2258 11.1 18126 88.9 20384 
 Female 5621 11.1 44745 88.9 50366 
Race White 4186 12.6 26122 87.4 33308 
 Black 2763 10.4 23654 89.5 26417 
 Other 930 8.4 10095 91.6 11025 
Age Under 70 948 7.0 12549 93.0 13497 
 71-89 5229 11.2 41537 88.8 46766 
 Over 90 1702 16.2 8785 83.7 10487 
CHF No 913 9.7 8437 90.2 9350 
 Yes 3477 10.0 31104 89.9 34581 
COPD No 1869 9.9 16976 90.0 18845 
 Yes 2521 10.0 22565 89.9 25086 
  This time a GEE with a binary logistic distribution and robust variance estimates 
was estimated to predict death using ER visits and the confounding variables of age, 
gender, race and COPD and CHF status were included. Similar to the previous model, 
separate parameters were used for both COPD and CHF status, which assumes the effect 
of both on death outcome is additive. A correlation matrix with an exchangeable structure 
was used. Type I tests for the second model are presented in Table 7. Based on these 
findings we accept that ER visits had no significant relationship with death in a given 
year, therefore we accept the null hypothesis. The confounding variables of age and race 
were both found to be significant. To estimate the effect of these variables on death, the 





Table 7.  
Significance of Variables Included in the Model for Research Question 2.  
Variable Wald Chi Square df P value 
Intercept 16087.04 1 < 0.001 
Gender 2.22 1 0.13 
Age (categorical) 339.05 2 < 0.001 
Race (categorical) 120.19 2 < 0.001 
CHF 0.327 1 0.56 
COPD 0.646 1 0.42 
ER Visits 0.000 1 0.98 
This model has the following formula: 
Dij ~ Bernoulli(Yij) 
Log(Yij/1- Yij) = β0 + β1 gi + β2 xi + β3 zi + β4 vij + β5wi + β6bi + β7hi + β8ci + εij 
where Dij is the death outcome of subject i in year j, gi is equal to 1 if subject i is 
male, 0 otherwise, vij is the number of ER visits for subject i in year j, xi is equal to 1 if 
the subject is aged 70 or under, 0 otherwise, zi is equal to 1 if the subject is aged between 
71 and 89, 0 otherwise, wj is equal to 1 if the subject is white, 0 otherwise, and bj is equal 
to 1 if the subject is black, 0 otherwise. hi is equal to 1 is the subject does not have CHF 
and ci is equal to 1 if the subject does not have COPD, 0 otherwise for both. εij is the error 
term for subject i in year j. Parameter estimates for this model are presented in Table 8.  
The two variables found to be significant were age and race. Being aged 70 and 
below was found to decrease the odds of death by .65 compared to being aged over 90. 
Being aged between 71 and 89 was found to decrease the odds of death by .35 compared 
to being aged over 90. Being white was found to increase the odds of death by .68 
74 
 
compared to being in the ‘other racial category. Finally, being black was found to 
increase the odds of death by .47 compared to being in the ‘other’ racial category.  
Table 8.  
Parameter Estimates.  
Parameter Β Std Error E^β Wald Stat df P value 
Intercept (β0) -2.09 0.06 0.12 1269.79 1 < 0.001 
ER Visits (β0) -0.001 0.04 0.99 0.00 1 0.98 
Gender = Male (β0) 0.06 0.03 1.06 3.77 1 0.05 
Gender = Female       
Age 70 and below (β0) -1.03 0.06 0.35 334.09 1 < 0.001 
Age between 71-89 (β0) -0.42 0.04 0.65 105.75 1 < 0.001 
Age above 90       
Race White (β0) 0.52 0.05 1.68 119.48 1 < 0.001 
Race Black (β0) 0.39 0.05 1.47 61.66 1 < 0.001 
Race Other       
Does not have CHF (β0) -0.03 0.04 0.97 0.76 1 0.38 
Has CHF       
Does not have COPD 
(β0) 
-0.03 0.03 0.97 0.645 1 0.42 
Has COPD       
Summary 
The purpose of this study was to determine what variables contributed to 
increased ER visits and death among Medicaid and Medicare beneficiaries whom are 
identified with CHF or COPD in the state of Maryland, using a sample from the 
MMLEADS in the years 2010, 2011 and 2012. This was done using two GEE type 
regression equations to determine which variables such as age, gender, PCP availability 
and race significantly affect either ER visits or death outcome for a given year. Increased 
PCP was found to significantly decrease the number of ER visits when controlling for 
other confounding variables. Alternatively, persons living in areas with higher PCP also 
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had lower ER visits. It is likely that the classification of PCP categories could affect this 
finding, and future studies may need to use a broader definition of a primary care 
provider. There was no significant relationship found between the number of ER visits 
and death outcome in a given year. The broader implications of these results will be 













Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
Medicare and Medicaid recipients across the country aged 65 and older are a 
resource intensive population for which CHF and COPD are an ongoing issue (Dalal, 
Shah, Lunacsek, & Hanania, 2011; MPAC, 2009). In Maryland, ED visits are on the rise, 
and between 1990 and 2001, ER visits increased from 1.5 million to 1.9 million across 
the United States (Aziz et al., 2011; Garcia et al., 2010; Kociol et al., 2013; Lucas et al., 
2009). Because of these increases, hospital administration decided to use temporary 
closings as a cost cutting measure, a decision that influenced ambulatory services through 
increased utilization (Fwu et al., 2013). The designation of resource intensive clientele 
refers to frequent ED users, as they are more likely to arrive by ambulance and receive a 
bed within the hospital for services (LaCalle & Rabin, 2010; Locker et al., 2007; Ruger et 
al. 2004). 
Most in American society are unwilling to pay the costs associated with caring for 
frequent ED users, who are likely to be, according to research, poor, male, socially 
isolated, chronically, and psychologically ill alcoholics (Mandelberg, Kuhn, & Kohn, 
2000). Thus, the impetus is to find a way to lower costs without closing ERs; therefore, 
this study was both relevant and necessary.  
The current quantitative study was a retrospective cross sectional study designed 
to explore the connection between Maryland Medicare and Medicaid beneficiaries with 
CHF and COPD and frequent emergency room use and cost. It was conducted both to 
evaluate the impact of ED usage on patients from the aforementioned demographic, and 
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to add to the current research on ways to lower costs to Maryland hospitals through 
preventive services designed to reduce ED utilization (Burt & McCaig 2001).  
This chapter will discuss and interpret the findings of the study and point to the 
potential implications of the study findings on hospital EDs across the United States. In 
addition, the chapter will conclude with recommendations for further research. 
Discussion 
The primary research objective was to examine the importance of primary care 
provider usage for Medicare and Medicaid patients with CHF or COPD, at the 
community and individual levels, as they relate to episodic, persistent, and frequent ED 
usage during the calendar years of 2010 and 2012. Secondarily, the research sought to 
determine if frequent visits to the ED were associated with end of life for the same 
population in those same years.  
Two research questions informed the research in this study: 
1. Is the PCP supply in the State of Maryland associated with frequent ED 
use among Maryland Medicare and Medicaid beneficiaries who have CHF 
or COPD?  
2. Is frequent ED use associated with end of life for Maryland Medicare and 
Medicaid beneficiaries with either CHF or COPD who die during the 
study? 
I used the study to either confirm or deny the association through the collection 
and analysis of data, or alternately, that there was a definite connection between the two 
phenomena studied within each question.  
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Interpretations of the Findings 
Hypothesis 1 and 1a 
The presumption (Hypothesis 1) was that either there would be no significant 
difference in the number of ER visits for any gender, race, or age of Medicare or 
Medicaid beneficiaries as a result of an increase in PCPs, or alternately, (Hypothesis 1a), 
that there would be a significant difference due to the increase. Tests of the data collected 
determined that the year with the lowest number of PCPs included 2010, which coincided 
with the highest number of emergency room visits by patients with CHF and COPD, thus 
proving the first supposition to be true.  
The measure of the probability that the researcher’s assumptions are correct (its p-
value) was calculated to determine the presence or absence of statistical errors in the data. 
A p-value that is calculated to be less than or equal to 0.05 indicates that the first 
presumption (Hypothesis 1) was not acceptable, and that the researcher must then accept 
the alternative assumption (Hypothesis 1a). In this case, the data indicating the rate of the 
yearly PCP increase, gender, and age, all have p-values of less than 0.05, thus the first 
presumption, that there would be no difference in the rate of ER usage relative to age, and 
gender, was rejected, proving that there was indeed a relationship between these 
variables.  
The analysis of p-value also revealed that gender played a significant part, as rates 
of ER visits for males were higher compared to those for females, increasing slightly 
during each year studied. Additionally, patient age was also positively correlated. Perhaps 
surprisingly, being aged 71 to 89 was negatively related to ER visit frequency, with the 
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number of visits decreasing, instead of increasing as alternate hypothesis suggested, each 
year when compared with the number of visits for patients aged 70 years or less. 
Remarkably, for patients over the age of 90, ER visits also decreased a small percentage 
annually as compared with those of patients 70 and younger.  
Because it showed a higher p-value, the variable of race was not statistically 
significant enough to reject the null hypothesis in research question one. The p-values for 
data relative to race were larger, with a p-value of .09, indicating that the researcher could 
not reject Hypothesis 1. Thus, for age and gender only, the alternate hypothesis 
(Hypothesis 1a), which stated that there would be a significant difference in ER usage 
due to the increase in PCP’s was affirmed.  
Hypothesis 2 and 2a 
Another research question posed in this study indicated the extent to which 
frequent use of the ED was associated with end of life for Medicare and Medicaid 
beneficiaries with CFH or COPD with regard to age, race, and gender. The presumption 
was that increased emergency room visits would not influence death rates (Hypothesis 2), 
while the alternate view (Hypothesis 2a) suggested that it would. Results of the data 
analysis showed that frequency of ER visits had no significant impact on end of life for 
Medicare or Medicaid beneficiaries with COPD or CHF concerning gender as the p-value 
was calculated to be 0.89, much higher than the .05 necessary to reject the Hypothesis 2. 
Race and age however, proved to be significant due to p-values that were less than .001, 
showing that Whites and patients under the age of 70 had higher rates of death than those 
from other racial and age groups relative to frequency of ER visitation. Interestingly, 
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patients under the age of 70 were the least likely of all age categories to die, regardless of 
ER visit frequency. 
The current study explored the correlation between ER visits and death among 
Medicaid and Medicare beneficiaries in Maryland identified to have CHF or COPD. The 
researcher used comparisons of age, gender, and race to determine rates of death as they 
related to frequency of ER visitation and death. A review of the literature reveals both 
confirmation and disconfirmation of the current study’s findings, a fact that does not 
disqualify the results, but helps to extend the knowledge of the field.  
The theoretical premise utilized in the study relates to Andersen’s (2008) model 
of health behavior. I addressed this theory using demographic statistics concerning 
Medicare and Medicaid patients with CHF and COPD as they relate to age, race, and 
gender, by indirectly speaking to the concept of service equality within the context of 
perceived need, resource allocation, and predisposing characteristics. Within this context, 
need has been proven to be the greatest determinant of health services usage (Andersen, 
2008). However, when need is surpassed by concerns about resources or predisposition 
characteristics, equality of services can become questionable.  
In direct contrast to the findings in this report, a study by O’Neil et al. (2010) 
reveals that rates of hospitalization by race for ambulatory care sensitive conditions such 
as CHF and COPD differed considerably from those alluded to in the current study. 
According to the authors, African Americans with Medicare in Maryland had 
significantly higher rates of ACSC hospitalizations for congenital heart failure than any 
other race, while Whites had significantly higher rates of hospitalization for COPD 
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compared to other races (O’Neil et al., 2010). The current study’s findings differ in that it 
lists the rates of frequency of emergency room visits as significantly higher for Whites 
than for any other race, though it did not delineate rates for COPD alone, instead 
combining it with CHF and presenting the resultant findings as a whole and utilizing data 
about ER visitations only.  
I used variables, such as age, ER visits, ER claims, payment amounts, gender, 
race, and rates of death and disease, to assess utilization and costs of Medicare and 
Medicaid beneficiaries identified as having CHF and COPD. The statistics served to 
demonstrate Andersen’s (2008) premise that health coverage usage may determine 
equality of services. I determined that the variables that contributed to decreased ER 
visits of CHF/COPD in the years 2010, 2011, and 2012 related to the supply of PCPs 
available during those years. This study’s findings that the year with the lowest ratio of 
PCPs per CHF and COPD patients had higher ER rates compared to other years, seems to 
coincide with Andersen’ premise that access to services not based on need leads to 
inequality of service, and thus the over usage of ER services and financial burden on area 
hospitals (Buccaneer, 2011; ccwdata.org). The implications of the study speak to the 
impact of access to PCP’s and the possibility that preventative care can positively 
contribute to patient health as it relates to ED usage for Medicare and Medicaid 
beneficiaries with either COPD or CHF.  
Biello et al. (2010) suggested that African Americans were more likely than other 
races to be hospitalized for chronic diseases at younger ages, a fact that O’Neil et al. 
(2010) attributed to racial disparities in the type and extent of medical services available 
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in their communities. The researcher determined that hospitalization at younger ages 
could negatively affect the quality of life for the patient due to loss of wages, and risk of 
further hospitalizations and severity of illness. The researcher did not look at 
hospitalization overall, but focused on ED visitation amongst Medicaid and Medicare 
beneficiaries only, as reported by the Administrative Claims Data files in CCW. The 
sample size included 100% of the claims data for the years 2010 to 2012, and a 20 
percent, or two million, client sample of the Medicare claims as reported by the CCW 
during the same period (CCW, 2015). 
Because of its focus on ED visitation only, the results differ from the more 
broadly scoped studies of hospitalization as a whole. While the researcher in the current 
study also concluded that patients under the age of 70 had the highest rates of ER 
visitation, (which could coincide with the higher rates of hospitalization for younger 
African Americans), it also concluded that Whites had the highest average of ER visits 
when compared to other races. Thus, the previous literature both confirms and 
disconfirms the study results in this area.  
Another area of apparent disagreement between this study and those utilized in 
the literature review involves the idea that there is a significant difference in how many 
men make more trips to the ER than women. Tsai et al. (2007) and Watson et al. (2004) 
found no difference in ER visits by gender, and yet the current study’s findings that men 
made more visits to the emergency room at a rate of .01 higher than women, is 
contradictory. The results of the current study may extend the previous research due to 
the difference in sample size utilized. In a study with a small sample size, the difference 
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between a mean of .06 and a mean of .07 may not be as significant, but the extremely 
large sample size, (about 2 million prior to subdivision), utilized in this study makes for a 
substantial difference, making sample size a confounding variable in this study.  
Another phenomenon studied references expenses for ED usage per year. The 
findings, that the Medicaid and Medicare payments for ER usage by CHF and COPD 
patients was highest in the year with the lowest PCP accessibility, coincides with Aziz et 
al. (2011) and Kociol et al.’s (2013) studies on the conditions. These researchers 
determined that CHF and COPD represented conditions with the highest admission and 
readmission rates, thus the costs to Medicare and Medicaid are significant.  
Some factors, not presented as a part of this study, include the rates of 
hospitalization and rehospitalization and its relation to the death of Maryland Medicare 
and Medicaid beneficiaries with CHF and or COPD. Although much of the literature 
reviewed detailed the rates of hospitalization for the aforementioned population, a study 
of death rates for this particular group is not included. The current study results indicated 
the rates of death for this population, based on findings using data from a sample size of 
up to 2 million Medicare and Medicaid beneficiaries, but did not address a possible 
correlation between the two ideas.  
A recommendation for future research applies to the findings in this study that 
look at the relationship between primary care providers and frequency of ED usage. The 
inclusion of demographic data relative to PCPs and ER usage, paired with hospitalization, 
rehospitalization, and death statistics could present a clear picture of the disparities 
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alluded to by Andersen (2008), the primary theoretical framework of this study, and 
could extend the previous research considerably.  
The current study results align with the methodology of the research in the field, 
as claimant information for Medicaid and Medicare beneficiaries is accessible. Other 
studies also observed data related to racial disparities, chronic disease trends, and costs of 
care on the Medicaid and Medicare population.  
Limitations of the Study 
The study’s design and implementation has inherent limitations. The most 
prominent limitation is within the design of the study. Because the researcher used an 
observational retrospective cross-study design with a large sample population, the 
question of external validity is considered. The researcher was limited in the use of PCPs 
as alternative care groups such as Physician’s Assistants, Nurse Practitioners, and family 
doctors were not included in this study. In addition, the types of data that the researcher 
could measure and compare due to reliance on Administrative Claims Data from CCW 
was an issue. Although the data used in the study produced valuable information about 
Medicare and Medicaid beneficiaries’ primary care physician status in Maryland, it did 
not differentiate ER usage rates by state, by socioeconomic status, or by hospital, thereby 
leaving a gap in an important research area that could have been useful to extend the 
research. Thus, the data, while useful as a whole, does not necessarily provide Maryland 
hospital administration and lawmakers with the types of generalized information needed 




The limitations of the study reveal a possible area of potential for future 
researchers. To extend the research, there is a need for additional studies designed to 
isolate the independent variables relative to geography, patient income, and hospital 
spending as it relates to re-hospitalization and death. Further research is needed to include 
alternative sources of care such as Physician’s Assistants, Nurse Practitioners and family 
doctors in addition to elucidate the relationships between variables. Low-income patients 
for example, may be less willing to seek medical treatment regularly due to the costs 
associated with doctor’s appointments and or prescription purchasing, a decision that 
could negatively influence ED spending as chronic illnesses are worsened and acute care 
is needed. Geography’s impact on ER spending could also be important in that 
geographic areas in Maryland, like all states, likely contain geographic areas populated 
based on income and access to services, thus creating an overuse of ED services, which 
in turn raises costs and affects service quality.  
In the future, researchers could use a mixed research methodology for a case 
study, rather than relying solely on data taken from Administrative Claims Data in CCW. 
A mixed research model could offer insights into individual patients’ reasoning behind 
using emergency room services rather than taking actions, such as healthy lifestyle or 
primary care services, that may have prevented their chronic condition from worsening. 
The combination of in depth case studies relative to Maryland ED usage and quantitative 
data could be a powerful way to bridge the gap and put a more human face on the data. 
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A study of the effects of age, race, gender, and cost on the consistency and quality 
of treatment for chronic health conditions could bring to light many of the concepts and 
correlational characteristics mentioned in the literature review with reference to the 
epidemiological triad model of person, time and place (Anderson, 2008). Future research 
could indicate how variables such as the financial burden, on families, hospitals and the 
state of Maryland, influence the treatment of CHF and COPD, and spur the development 
of preventive measures designed to curb health care costs among Medicare and Medicaid 
beneficiaries, while optimizing health.  
Implications  
The study findings have the potential for real positive change; however, the 
limitations of the study may limit its impact. The study problem, combined with the 
available research indicates that more research is needed to determine the scope of the 
problem as it relates to geographical and racial disparities, and what, if anything, can be 
done to eliminate the overcrowding of EDs in Maryland and other states. The findings 
correlated to PCP supply and lowered ER costs have the possibility of positively 
impacting hospital spending on ED services, as preventative care creates positive change 
in the quality of life for ACSC patients. This may be achieved by increasing the supply of 
nurse practitioners, physician assistance and family doctors. Furthermore, since ED visits 
are not associated with mortality, programs should try to divert patients to less expensive 
care sites such as retail medicine, after-hour clinics, and online visits. 
The results of the study indirectly support the theoretical framework of the 
epidemiological triad through the statistical acknowledgement of the relationships 
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specifically between behavior, ecological and environmental factors, and lifestyle and 
physical factors and chronic diseases. The implications of the study also positively 
correlate to Andersen’s (2008) Model of Health Behavior as it potentially exposes the 
predisposing characteristics, enabling resources and need relevant to CHF and COPD 
patients. The statistical significance of financial impact, race and age correlates within the 
study have the potential of bringing clarity to the theoretical framework, and suggest that 
corrections to access to services could result in significant change.  
The study results combined with the theoretical framework can guide further 
research in determining the optimal PCP supply, and costs analysis of ACSC response to 
preventative medicine, which in turn could help researchers to develop a plan to even the 
playing field with regard to equality of care. With a projected 127 percent growth in the 
number of Americans living with chronic illnesses by the year 2020, the vast majority of 
those individuals will be living under the poverty line (Bodenheimer, Chen, & Bennett, 
2009). Insight into racial, socioeconomic, and geographical disparities could yield 
research that promotes positive social change. However, a limitation of the current study 
is that its data does not necessarily coincide with other studies in that the findings did not 
show the racial, socioeconomic or geographical disparities highlighted in much of the 
literature. Policy makers can utilize the information obtained in this and future studies to 
understand the impact of age, gender, and race on supply of PCPs on Medicare and 
Medicaid patients, and their impact on hospital ED spending. Hence, this research has the 
potential to inform health care delivery system and also improve existing and emerging 




I used a quantitative, observational, and retrospective cross-study design to 
answer the following research questions: Is the primary care provider (PCP) supply in a 
state associated with frequent ED use among Maryland Medicare and Medicaid 
beneficiaries who have CHF or COPD? Is frequent ED use associated with end of life for 
Maryland Medicare and Medicaid beneficiaries with either CHF or COPD who die 
during the study? The prevalence of Medicare and Medicaid beneficiary utilization of 
emergency room services are in direct correlation with the amount of PCPs that are 
accessible. Therefore, the answers to these questions could help the state of Maryland to 
develop new programs and adjust current practices related to the rising costs of 
emergency room care relative to overuse, and simultaneously improve health outcomes or 
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Appendix B  
CHF and COPD Codes 
CHF Codes used in this study were: 39891, 40201, 40211, 40291, 40401, 40403, 40491, 
40493, 4280, 4281, 42820, 42821, 42822, 42823, 42830, 42831, 42832, 42833, 42840, 
42841, 42842, 42943, 4289. 
COPD Codes used in this study were: 490, 4910, 4911, 4918, 4919, 4920, 4928, 49120, 





Primary Care Physician Codes Used in This Study 
 
Code Description 
01 General Practice 
08 Family Practice 
11 Medicine 
38 Geriatric Medicine 
 
